Wataru Yasui

Last Updated :2017/09/01

Affiliations, Positions
Graduate School of Biomedical & Health Sciences (Biomedical Sciences Major), Professor
Web Site
E-mail
wyasuihiroshima-u.ac.jp
Self-introduction
Pathology is an integrated medical science that studies the causes and mechanisms of disease, and is the foundation of medical science and practice. There are two main pillars in pathology; pathological diagnosis and experimental pathology. We place equal emphasis on both fields at our laboratory, and widely contribute to clinical practice and development of advanced medicine.

Basic Information

Major Professional Backgrounds

  • 1986/04/01, 1987/06/30, Hiroshima University, First Department of Pathology, Research Assistant
  • 1987/07/01, 1989/04/30, Research Institute of Scripps Clinic, Dept. of Molecular and Experimental Medicine, Research Fellow
  • 1989/08/01, 1992/09/30, Hiroshima University, First Department of Pathology, Assistant Professor
  • 1992/10/01, 2000/05/31, Hiroshima University, First Department of Pathology, Associate Professor
  • 2000/06/01, 2002/03/31, Hiroshima University, First Department of Pathology, Professor
  • 2002/04/01, Hiroshima University, Department of Molecular Pathology, Professor
  • 2012/04/01, 2013/03/31, Hiroshima University, Vice-Executive
  • 2013/03/15, Hiroshima University, Distinguished Professor
  • 2014/04/01, 2017/03/31, Hiroshima University, Institute of Biomedical & Health Sciences, Director
  • 2014/04/01, Hiroshima University, Graduate School of Biomedical & Health Sciences, Dean

Educational Backgrounds

  • Hiroshima University, Graduate School of Medical Sciences, Japan, 1982/04, 1986/03
  • Hiroshima University, Faculty of Medicine, Japan, 1976/04, 1982/03

Academic Degrees

  • Doctor of Medical Science, Hiroshima University
  • Doctor of Medicine, Hiroshima University

Educational Activity

  • School of Medicine:Program of Medicine, Graduate School of Biomedical & Health Sciences:Medical and Dental Sciences Major, Graduate School of Biomedical & Health Sciences:Biomedical Sciences Major

Research Fields

  • Medicine,dentistry, and pharmacy;Basic medicine;Human pathology

Research Keywords

  • Tumor Molecular Moprhology
  • Molecular Pathological Diagnosis
  • Global gene expression analysis
  • Transcriptome Dissection, SAGE, CAST
  • Molecular Basis of Gastrointestinal Cancer
  • Molecular Basis of Urological Cancer
  • Identification of Novel Diagnostic and Therapeutic Targets
  • non-coding RNAs
  • Gene Regulation and Epigenetics
  • Cancer Stem Cell

Affiliated Academic Societies

  • Japanese Society of Pathology, 1982
  • Japanese Cancer Association, 1998
  • Japanese Gastric Cancer Association, 1998
  • American Association for Cancer Research, 1992
  • The International Gastric Cancer Association, 1995
  • International Academy of Pathology, 1989
  • International Society of Gastroenterological Carcinogenesis (ISGC), 1996
  • Japanese Society for Gastroenterological Carcinogenesis, 1995
  • Japanese Society of Clinical Cytology, 1990
  • Japanese Association for Metastasis Research, 1998
  • Japanese Society of Gastroenterology, 1994
  • Japanese Society of Molecular Pathology, 1989
  • Japanese Society for Molecular Tumor Marker Research, 1989
  • The Japanese Biochemical Society, 1982

Educational Activity

Course in Charge

  1. 2017, Undergraduate Education, Second Semester, Early exposure of undergraduates to medicine
  2. 2017, Undergraduate Education, Intensive, Pathology
  3. 2017, Undergraduate Education, Intensive
  4. 2017, Undergraduate Education, 2Term, Introduction for medical research
  5. 2017, Undergraduate Education, Intensive, Practice for medical research
  6. 2017, Undergraduate Education, First Semester, General Pathology
  7. 2017, Undergraduate Education, Intensive, Clinical Clerkship (Advanced Course)
  8. 2017, Undergraduate Education, First Semester, Pathology
  9. 2017, Undergraduate Education, First Semester, Pathology
  10. 2017, Undergraduate Education, Intensive, Pathology
  11. 2017, Undergraduate Education, First Semester, Outline of Pathology
  12. 2017, Liberal Arts Education Program1, 1Term, Introductory Seminar for First-Year Students
  13. 2017, Graduate Education (Master's Program) , First Semester, Methods in biomedical sciences
  14. 2017, Graduate Education (Master's Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  15. 2017, Graduate Education (Master's Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  16. 2017, Graduate Education (Master's Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  17. 2017, Graduate Education (Master's Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  18. 2017, Graduate Education (Master's Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  19. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  20. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  21. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  22. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  23. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  24. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  25. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  26. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  27. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  28. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  29. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  30. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical & Health Sciences
  31. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical Technology and Informatics
  32. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical Technology and Informatics
  33. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical Technology and Informatics
  34. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical Technology and Informatics
  35. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical Technology and Informatics
  36. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical Technology and Informatics
  37. 2017, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical Technology and Informatics
  38. 2017, Graduate Education (Master's Program) , Second Semester, Special Course of Biomedical Technology and Informatics
  39. 2017, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  40. 2017, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  41. 2017, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  42. 2017, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  43. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Methods in biomedical sciences
  44. 2017, Graduate Education (Doctoral Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  45. 2017, Graduate Education (Doctoral Program) , Second Semester, Start-Up Coursework of Biomedical Sciences
  46. 2017, Graduate Education (Doctoral Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  47. 2017, Graduate Education (Doctoral Program) , First Semester, Start-Up Coursework of Biomedical Sciences
  48. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Coursework of Biomedical Sciences
  49. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Coursework of Biomedical Sciences
  50. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Coursework of Biomedical Sciences
  51. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Coursework of Biomedical Sciences
  52. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  53. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  54. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  55. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  56. 2017, Graduate Education (Doctoral Program) , First Semester, English Presentation
  57. 2017, Graduate Education (Doctoral Program) , Second Semester, English Presentation
  58. 2017, Graduate Education (Doctoral Program) , First Semester, English Presentation
  59. 2017, Graduate Education (Doctoral Program) , Second Semester, English Presentation
  60. 2017, Graduate Education (Doctoral Program) , First Semester, English Presentation
  61. 2017, Graduate Education (Doctoral Program) , Second Semester, English Presentation
  62. 2017, Graduate Education (Doctoral Program) , First Semester, English Presentation
  63. 2017, Graduate Education (Doctoral Program) , Second Semester, English Presentation
  64. 2017, Graduate Education (Master's Program) , Second Semester, Pathologic basis of diseases
  65. 2017, Graduate Education (Master's Program) , First Semester, Seminar on Molecular Pathology
  66. 2017, Graduate Education (Master's Program) , Second Semester, Seminar on Molecular Pathology
  67. 2017, Graduate Education (Master's Program) , First Semester, Research on Molecular Pathology
  68. 2017, Graduate Education (Master's Program) , Second Semester, Research on Molecular Pathology
  69. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Molecular Pathology
  70. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Molecular Pathology
  71. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced research on Molecular Pathology
  72. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Molecular Pathology

Research Activities

Academic Papers

  1. KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells, ANTICANCER RESEARCH, 37(1), 47-55, JAN 2017
  2. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer, ANNALS OF SURGICAL ONCOLOGY, 24(2), 594-602, FEB 2017
  3. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 35(1), JAN 2017
  4. BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis, ELIFE, 6, JAN 10 2017
  5. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression, CANCER SCIENCE, 108(1), 143-150, JAN 2017
  6. Characteristic expression of fukutin in gastric cancer among atomic bomb survivors, ONCOLOGY LETTERS, 13(2), 937-941, FEB 2017
  7. SIX1 maintains tumor basal cells via transforming growth factor- pathway and associates with poor prognosis in esophageal cancer, CANCER SCIENCE, 108(2), 216-225, FEB 2017
  8. Regeneration of rat corpora cavernosa tissue by transplantation of CD133(+) cells derived from human bone marrow and placement of biodegradable gel sponge sheet, ASIAN JOURNAL OF ANDROLOGY, 19(2), 203-207, MAR-APR 2017
  9. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact, NEOPLASIA, 19(5), 429-438, MAY 2017
  10. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma, ANTICANCER RESEARCH, 37(6), 2853-2860, JUN 2017
  11. Regression of Cecal MALT Lymphoma after Antibiotic Treatment in a Patient with Helicobacter pylori Infection, INTERNAL MEDICINE, 55(2), 135-139, 2016
  12. TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer, GASTRIC CANCER, 19(2), 370-380, APL 2016
  13. Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer, GASTRIC CANCER, 19(2), 443-452, APR 2016
  14. A case of tubulocystic carcinoma of the kidney with aggressive features, JAPANESE JOURNAL OF RADIOLOGY, 34(4), 307-311, APR 2016
  15. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras, JOURNAL OF GASTROENTEROLOGY, 51(5), 447-457, MAY 2016
  16. Induction of KIFC1 expression in gastric cancer spheroids, ONCOLOGY REPORTS, 36(1), 349-355, JUL 2016
  17. Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma, CANCER SCIENCE, 107(5), 601-608, MAY 2016
  18. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation, ONCOGENE, 35(27), 3598-3606, JUL 7 2016
  19. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma, CANCER MEDICINE, 5(7), 1546-1555, JUL 2016
  20. Increased Calcineurin A Expression Is Associated with a Lower Relapse-Free Survival Rate after Colorectal Cancer Surgery, PATHOBIOLOGY, 83(6), 308-315, 2016
  21. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer, ONCOGENESIS, 5, AUG 2016
  22. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, SEP 9 2016
  23. ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN, ONCOGENE, 35(34), 4447-4458, AUG 2016
  24. Balloon Cell Malignant Melanoma in a Young Female: A Case Report and Review of the Literature, CASE REPORTS IN ONCOLOGY, 9(1), 262-266, 2016
  25. Overexpression of KIF11 in Gastric Cancer with Intestinal Mucin Phenotype, PATHOBIOLOGY, 84(1), 16-24, SEP 2016
  26. Clinicopathologic characteristics and management of minute esophageal lesions diagnosed by narrow-band imaging endoscopy, ENDOSCOPY INTERNATIONAL OPEN, 4(9), E927-E932, SEP 2016
  27. Pure invasive micropapillary carcinoma of the esophagogastric junction with lymph nodes and liver metastasis, PATHOLOGY INTERNATIONAL, 66(10), 583-586, OCT 2016
  28. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation, PLOS ONE, 11(11), NOV 11 2016
  29. Russell body gastritis concurrent with eosinophilia: a case report, Hiroshima J Med Sci, 65(3-4), 69-72, 2016
  30. Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice, PLOS ONE, 10(7), JUL 17 2015
  31. Characteristic miR-24 Expression in Gastric Cancers among Atomic Bomb Survivors, PATHOBIOLOGY, 82(2), 68-75, 2015
  32. Vasculo-smooth muscle hamartomatous structure is linked to morphogenesis of colorectal polypoid adenoma, MEDICAL MOLECULAR MORPHOLOGY, 48(2), 112-115, JUN 2015
  33. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype, CANCER SCIENCE, 106(8), 951-958, AUG 2015
  34. Aberrant DNA Methylation of DLX4 and SIM1 is a Predictive Marker for Disease Progression of Uterine Cervical Low-Grade Squamous Intraepithelial Lesion, DIAGNOSTIC CYTOPATHOLOGY, 43(6), 462-470, JUN 2015
  35. High-grade epithelial-myoepithelial carcinoma of the parotid gland with mucous cell differentiation, PATHOLOGY INTERNATIONAL, 65(9), 490-494, SEP 2015
  36. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer, PATHOBIOLOGY, 82(5), 233-241, 2015
  37. The relationship between inflammation and neoangiogenesis of epicardial adipose tissue and coronary atherosclerosis based on computed tomography analysis, ATHEROSCLEROSIS, 243(1), 293-299, NOV 2015
  38. Stochastic resonance enhanced tactile feedback in laparoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(12), 3811-3818, DEC 2015
  39. The Potential Role of Inflammation Associated with Interaction between Osteopontin and CD44 in a Case of Pulmonary Tumor Thrombotic Microangiopathy Caused by Breast Cancer, INTERNAL MEDICINE, 54(22), 2877-2880, 2015
  40. TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer, CANCER MEDICINE, 4(11), 1667-1678, NOV 2015
  41. Alpha-fetoprotein-producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation, MEDICAL MOLECULAR MORPHOLOGY, 47(1), 54-56, MAR 2014
  42. Canonical Wnt signals combined with suppressed TGF beta/BMP pathways promote renewal of the native human colonic epithelium, GUT, 63(4), 610-621, APR 2014
  43. Clinicopathological significance of MMP-7, laminin gamma 2 and EGFR expression at the invasive front of gastric carcinoma, GASTRIC CANCER, 17(3), 412-422, JUL 2014
  44. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer, INTERNATIONAL JOURNAL OF CANCER, 134(8), 1926-1934, APR 15 2014
  45. Identification of Novel Transmembrane Proteins in Scirrhous-Type Gastric cancer by the Escherichia coli Ampicillin Secretion Trap (CAST) Method: TM9SF3 Participates in Tumor Invasion and Serves as a Prognostic Factor, PATHOBIOLOGY, 81(3), 138-148, 2014
  46. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 32(6), 769-778, AUG 2014
  47. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer, CANCER SCIENCE, 105(2), 228-235, FEB 2014
  48. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer, ONCOLOGY REPORTS, 32(4), 1720-1726, OCT 2014
  49. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis, CANCER SCIENCE, 105(2), 236-243, FEB 2014
  50. NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression, CANCER SCIENCE, 105(1), 134-140, JAN 2014
  51. Oligophrenin-1 Is Associated with Cell Adhesion and Migration in Prostate Cancer, PATHOBIOLOGY, 81(4), 190-198, 2014
  52. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer, ONCOLOGY REPORTS, 32(1), 403-410, JUL 2014
  53. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-alpha secretion in gastric cancer, ONCOGENE, 33(30), 3918-3926, JUL 24 2014
  54. Canonical Wnt signals combined with suppressed TGF beta/BMP pathways promote renewal of the native human colonic epithelium, GUT, 63(4), 610-621, 2014
  55. Interaction between bone marrow-derived mesenchymal stem cells and tumor cells induces expression of fibronectin in human colon cancer cells, CANCER RESEARCH, 74(19), 2014
  56. Combining Molecular Targeted Drugs to Inhibit Both Cancer Cells and Activated Stromal Cells in Gastric Cancer, NEOPLASIA, 15(12), 1391-1399, DEC 2013
  57. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells, GASTRIC CANCER, 16(3), 345-354, JUL 2013
  58. Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature, VIRCHOWS ARCHIV, 462(2), 239-248, FEB 2013
  59. Expression of olfactomedin 4 and claudin-18 in serrated neoplasia of the colorectum: a characteristic pattern is associated with sessile serrated lesion, HISTOPATHOLOGY, 62(7), 1018-1027, JUN 2013
  60. Expression of podoplanin/D2-40 in pericryptal stromal cells in superficial colorectal epithelial neoplasia, MEDICAL MOLECULAR MORPHOLOGY, 46(1), 20-23, MAR 2013
  61. Improved PCR amplification for molecular analysis using DNA from long-term preserved formalin-fixed, paraffin-embedded lung cancer tissue specimens, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 6(1), 76-79, 2013
  62. Meeting Report "MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA interference Joint International Symposium, 30 August 2012, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 579-582, 2013
  63. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma, INTERNATIONAL JOURNAL OF UROLOGY, 20(5), 468-477, MAY 2013
  64. MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/The 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43(5), 579-582, MAY 2013
  65. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers, ONCOLOGY REPORTS, 30(6), 2609-2616, DEC 2013
  66. Resistin-Like Molecule Is Abundantly Expressed in Foam Cells and Is Involved in Atherosclerosis Development, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 33(8), 1986-1993, AUG 2013
  67. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer, INTERNATIONAL JOURNAL OF CANCER, 132(4), 813-823, FEB 15 2013
  68. The Search for Secreted Proteins in Prostate Cancer by the Escherichia coli Ampicillin Secretion Trap: Expression of NBL1 Is Highly Restricted to the Prostate and Is Related to Cancer Progression, PATHOBIOLOGY, 80(2), 60-69, 2013
  69. A possible therapeutic agent for pulmonary fibrosis: Antibody against integrin alpha 8 beta 1, EUROPEAN RESPIRATORY JOURNAL, 42, 2013
  70. Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature (vol 462, pg 239, 2013), VIRCHOWS ARCHIV, 462(3), 369-369, 2013
  71. Interaction between bone marrow-derived mesenchymal stem cells and tumor cells induces metallothionein gene expression in human colon cancer, CANCER RESEARCH, 73(8), 2013
  72. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy., JOURNAL OF CLINICAL ONCOLOGY, 31(15), 2013
  73. Claudin-based paracellular proton barrier in the stomach, ANN NY ACADEMY OF SCIENCE, 1258, 108-114, 2012
  74. Clinicopathological features of minute pharyngeal lesions diagnosed by narrow-band imaging endoscopy and biopsy, WORLD JOURNAL OF GASTROENTEROLOGY, 18(44), 6468-6474, NOV 28 2012
  75. Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 19(6), 1902-1910, JUN 2012
  76. Cytokeratin Expression Profiling in Gastric Carcinoma: Clinicopathologic Significance and Comparison with Tumor-Associated Molecules, PATHOBIOLOGY, 79(3), 154-161, 2012
  77. Deficiency of Claudin-18 Causes Paracellular H+ Leakage, Up-regulation of Interleukin-1 beta, and Atrophic Gastritis in Mice, GASTROENTEROLOGY, 142(2), 292-304, FEB 2012
  78. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer, PATHOLOGY INTERNATIONAL, 62(2), 112-119, FEB 2012
  79. Infantile adenomyoma subclinically excreted into the patient's diaper, PATHOLOGY INTERNATIONAL, 62(8), 532-537, AUG 2012
  80. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer, CANCER SCIENCE, 103(9), 1744-1750, SEP 2012
  81. Meeting Report “Recent Progress in Carcinogenesis, Progression and Management of Upper GI Cancer: The 21st Hiroshima Cancer Seminar-the 5th Three Universities’ Consortium International Symposium, November 2011, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 351-356, 2012
  82. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD, JOURNAL OF CROHNS & COLITIS, 6(4), 425-434, MAY 2012
  83. Presence of vascular adventitial fibroblastic cells in diffuse-type gastric carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(9), 970-972, SEP 2004
  84. Primary mammary mucinous cystadenocarcinoma: Cytological and histological findings, DIAGNOSTIC CYTOPATHOLOGY, 40(7), 624-628, JUL 2012
  85. Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer, PLOS ONE, 7(11), NOV 2 2012
  86. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis, CARCINOGENESIS, 33(5), 1081-1088, 2012
  87. SAGE of esophageal squamous cell carcinoma: identification of a new chemical biomarker in esophageal squamous cell carcinoma, NRD1, Japan Journal of Molecular Tumor Marker Research, 27, 71-72, 2012
  88. A Functional Single Nucleotide Polymorphism in Mucin 1, at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer, GASTROENTEROLOGY, 140(3), 892-902, MAR 2011
  89. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model, INTERNATIONAL JOURNAL OF CANCER, 128(9), 2050-2062, MAY 1 2011
  90. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma, HISTOPATHOLOGY, 59(4), 710-721, OCT 2011
  91. Future Perspective of Gastric Cancer Treatment - From Bench to Bedside - , PATHOBIOLOGY, 78, 293-294, 2011
  92. Identification of Transmembrane Protein in Prostate Cancer by the Escherichia coli Ampicillin Secretion Trap: Expression of CDON Is Involved in Tumor Cell Growth and Invasion, PATHOBIOLOGY, 78(5), 277-284, 2011
  93. Meeting Report "Recent progress in carcinogenesis, progression and therapy of breast cancer. The 20th Hiroshima Cancer Seminar-the 4th Three Universities' Consortium International Symposium, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 924-930, 2011
  94. Molecular pathology of gastric cancer: Research and practice, PATHOLOGY RESEARCH AND PRACTICE, 207(10), 608-612, 2011
  95. Serum concentration and expression of Reg IV in patients with esophageal cancer: Age-related elevation of serum Reg IV concentration, ONCOLOGY LETTERS, 2(2), 235-239, MAR-APR 2011
  96. Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(46), 20027-20032, NOV 16 2010
  97. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor beta is associated with lymphatic metastasis in human gastric carcinoma, CANCER SCIENCE, 101(9), 1984-1989, SEP 2010
  98. Immunohistochemical analysis of colorectal cancer with gastric phenotype: Claudin-18 is associated with poor prognosis, PATHOLOGY INTERNATIONAL, 60(10), 673-680, OCT 2010
  99. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin, PATHOLOGY INTERNATIONAL, 60(4), 291-297, APR 2010
  100. Mesenchymal stem cells enhance growth and metastasis of colon cancer, INTERNATIONAL JOURNAL OF CANCER, 127(10), 2323-2333, NOV 15 2010
  101. Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 1(1), 73-78, JAN-FEB 2010
  102. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis, LANCET ONCOLOGY, 11(2), 136-146, FEB 2010
  103. Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype, JOURNAL OF PATHOLOGY, 221(3), 275-284, JUL 2010
  104. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma, CANCER SCIENCE, 101(4), 1038-1044, APR 2010
  105. Upregulation of Connexin 30 in Intestinal Phenotype Gastric Cancer and Its Reduction during Tumor Progression, PATHOBIOLOGY, 77(5), 241-248, 2010
  106. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase, ONCOGENE, 29(14), 2036-2046, APR 8 2010
  107. CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium, CANCER RESEARCH, 70(17), 6767-6778, 2010
  108. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma, CANCER SCIENCE, 101(4), 1038-1044, 2010
  109. Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells, CANCER SCIENCE, 101(10), 2121-2127, 2010
  110. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors, INTERNATIONAL JOURNAL OF CANCER, 124(5), 1112-1121, MAR 1 2009
  111. h-prune Is an Independent Prognostic Marker for Survival in Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 16(5), 1390-1396, MAY 2009
  112. Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer, CANCER RESEARCH, 69(16), 6694-6703, AUG 15 2009
  113. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker, ONCOLOGY REPORTS, 21(1), 95-100, JAN 2009
  114. Laminin gamma 2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells, GASTROENTEROLOGY, 137(1), 242-252, JUL 2009
  115. Meeting Report "Recent Progress in Pathogenesis and Management of Colorectal Cancer: The Eighteenth International Symposium of Hiroshima Cancer Seminar, November 2008, CANCER SCIENCE, 100, 978-981, 2009
  116. Reg IV enhances peritoneal metastasis in gastric carcinomas, CELL PROLIFERATION, 42(1), 110-121, FEB 2009
  117. Serum olfactomedin 4 (GWI 12, hGC4) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients, INTERNATIONAL JOURNAL OF CANCER, 125(10), 2383-2392, NOV 15 2009
  118. Transcriptome dissection of gastric cancer: Identification of novel diagnostic and therapeutic targets from pathology specimens, PATHOLOGY INTERNATIONAL, 59(3), 121-136, MAR 2009
  119. Recent progress in pathogenesis and management of colorectal cancer. Eighteenth International Symposium of the Hiroshima Cancer Seminar, November 2008, CANCER SCIENCE, 100(5), 978-981, 2009
  120. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach, MODERN PATHOLOGY, 21(4), 464-475, APR 2008
  121. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer, NATURE GENETICS, 40(6), 730-740, JUN 2008
  122. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma, CANCER SCIENCE, 99(9), 1806-1812, SEP 2008
  123. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(8), 1182-1189, AUG 2008
  124. In Silico analysis of Gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicity, MOLECULAR CANCER, 7, FEB 27 2008
  125. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastasis, ANTICANCER RESEARCH, 28(2B), 1169-1179, MAR-APR 2008
  126. Positive immunohistochemical staining of gamma H2AX is associated with tumor progression in gastric cancers from radiation-exposed patients, ONCOLOGY REPORTS, 20(5), 1131-1136, NOV 2008
  127. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis Fibrosis Stage III, HISTOLOGY AND HISTOPATHOLOGY, 23(4), 407-409, APR 2008
  128. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 21(5), 599-604, MAY 2008
  129. Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland, HISTOPATHOLOGY, 53(6), 667-675, DEC 2008
  130. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer, CANCER SCIENCE, 99(8), 1570-1577, AUG 2008
  131. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose, CANCER RESEARCH, 68(17), 7176-7182, SEP 1 2008
  132. Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms, CLINICAL CANCER RESEARCH, 14(22), 7205-7214, NOV 15 2008
  133. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis Fibrosis Stage III, HISTOLOGY AND HISTOPATHOLOGY, 23(4), 407-409, 2008
  134. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 21(5), 599-604, 2008
  135. Radiation therapy for Cancer - The Fifteenth Anniversary of Hiroshima Cancer Seminar Foundation, the Seventeenth International Symposium of Hiroshima Cancer Seminar, November 2007, CANCER SCIENCE, 99(6), 1287-1291, 2008
  136. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(8), 1182-1189, 2008
  137. Olfactomedin 4 and Reg IV: Novel Serum Biomarkers for Gastric Cancer Patients, TUMOR BIOLOGY, 29, 67-67, 2008
  138. Immunohistochemical Analysis and Serum Concentration of Reg IV in Patients with Esophageal Cancer, TUMOR BIOLOGY, 29, 79-79, 2008
  139. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high Reg IV serum level is associated with liver metastasis, Japan Journal of Molecular Tumor Marker Research, 23, 21-22, 2008
  140. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer, CLINICAL CANCER RESEARCH, 13(22), 6624-6631, NOV 15 2007
  141. Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer., CLINICAL CANCER RESEARCH, 13(22), 6624-6631, 20071115
  142. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas, CANCER RESEARCH, 67(24), 11601-11611, DEC 15 2007
  143. DNA demethylation of Vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 120(8), 1689-1695, APR 15 2007
  144. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer, CANCER SCIENCE, 98(1), 32-36, JAN 2007
  145. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer, CANCER SCIENCE, 98(12), 1902-1913, DEC 2007
  146. Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer, CANCER SCIENCE, 98(8), 1198-1205, AUG 2007
  147. Meeting Report "Cancer Stem Cell: The Sixteenth International Symposium of the Hiroshima Cancer Seminar, October 2006”, CANCER SCIENCE, 98, 753-756, 20070101
  148. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ONCOLOGY REPORTS, 18(2), 329-336, AUG 2007
  149. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy, ONCOGENE, 26(30), 4383-4393, JUN 2007
  150. Serum concentration of Reg IV in patients with colorectal cancer: Overexpression and high serum levels of Reg IV are associated with liver metastasis, ONCOLOGY, 72(5-6), 371-380, 2007
  151. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma, APMIS, 115, 1422-1425, 20070101
  152. Cancer stem cells - The Sixteenth International Symposium of the Hiroshima Cancer Seminar, October 2006, CANCER SCIENCE, 98(5), 753-756, 2007
  153. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ONCOLOGY REPORTS, 18(2), 329-336, 2007
  154. HMGB1-inducible MIA is associated with nodal metastasis in oral squamous cell carcinoma, CLINICAL & EXPERIMENTAL METASTASIS, 24(4), 288-289, 2007
  155. High expression of h-prune in gastric cancer with gastric phenotype : expression of h-prune is associated with poor survival in gastric cancer, CLINICAL & EXPERIMENTAL METASTASIS, 24(4), 291-291, 2007
  156. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma, APMIS, 115(12), 1422-1425, 2007
  157. Accumulation of DNA methylation is associated with tumor stage in gastric cancer, CANCER, 106(6), 1250-1259, MAR 15 2006
  158. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer, CANCER SCIENCE, 97(8), 737-745, AUG 2006
  159. Clinicopathologic and genetic characteristics of gastric cancer in young male and female patients, ONCOLOGY REPORTS, 16(1), 11-15, JUL 2006
  160. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors, ONCOLOGY REPORTS, 15(4), 933-938, APR 2006
  161. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas, VIRCHOWS ARCHIV, 448(4), 428-434, APR 2006
  162. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ANTICANCER RESEARCH, 26(1A), 49-54, JAN-FEB 2006
  163. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype, JOURNAL OF PATHOLOGY, 208(5), 633-642, APR 2006
  164. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion, CANCER RESEARCH, 66(21), 10439-10448, NOV 1 2006
  165. Gene expression profiles of small-cell lung cancers: Molecular signatures of lung cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 29(3), 567-575, SEP 2006
  166. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions, MOLECULAR AND CELLULAR BIOLOGY, 26(3), 898-911, FEB 2006
  167. Improved RT-PCR amplification for molecular analyses with long-term preserved formalin-fixed, paraffin-embedded tissue specimens, JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 54(7), 773-780, JUL 2006
  168. Lack of pericryptal fibroblastic cells adjacent to intestinal epithelial metaplastic glands, HISTOPATHOLOGY, 48, 610-612, 20060401
  169. Meeting Report "Current progress of cancer chemotherapy": The Fifteenth International Symposium of the Hiroshima Cancer Seminar, October 2005”, CANCER SCIENCE, 97, 328-331, 20060401
  170. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype, PATHOLOGY INTERNATIONAL, 56(4), 200-205, APR 2006
  171. Molecular pathobiology of gastric cancer, SCANDINAVIAN JOURNAL OF SURGERY, 95(4), 225-231, 2006
  172. Nuclear and mitochondrial DNA microsatellite instability in gastrointestinal stromal tumors, PATHOBIOLOGY, 73(2), 93-97, 2006
  173. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer, ONCOGENE, 25(17), 2546-2557, APR 2006
  174. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer, CANCER RESEARCH, 66(19), 9408-9419, OCT 1 2006
  175. Gene expression profiles of small-cell lung cancers: Molecular signatures of lung cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 29(3), 567-575, 2006
  176. A single nucleotide polymorphism in the 5 ' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer, PATHOBIOLOGY, 72(3), 133-138, 2005
  177. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan, ONCOLOGY REPORTS, 14(2), 465-470, AUG 2005
  178. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 131(1), 19-25, JAN 2005
  179. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer, VIRCHOWS ARCHIV, 447(4), 717-722, OCT 2005
  180. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage, CANCER SCIENCE, 96(9), 571-577, SEP 2005
  181. DNA methylation of genes linked with retinoid signaling in gastric carcinoma - Expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation, CANCER, 104(8), 1609-1619, OCT 15 2005
  182. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes, CANCER SCIENCE, 96(8), 474-479, AUG 2005
  183. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma, JOURNAL OF PATHOLOGY, 207(2), 185-198, OCT 2005
  184. G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell, CANCER IMMUNOLOGY IMMUNOTHERAPY, 54(8), 729-740, AUG 2005
  185. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression, ONCOLOGY, 69, 17-22, 2005
  186. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma, JOURNAL OF PATHOLOGY, 205(1), 65-73, JAN 2005
  187. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma, ONCOGENE, 24(1), 157-164, JAN 6 2005
  188. Meeting Report "Cancer and epigenetics - basic research and clinical implication - Joint Meeting of the Fourteenth International Symposium of the Hiroshima Cancer Seminar and the Eighth Meeting of the Tottori Bioscience Promotion Foundation, October 2004”, CANCER SCIENCE, 96, 245-248, 20050401
  189. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 21(5), 559-566, MAR 1 2005
  190. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population, ONCOLOGY REPORTS, 14(5), 1151-1154, NOV 2005
  191. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes, INTERNATIONAL JOURNAL OF CANCER, 115(3), 388-392, JUN 20 2005
  192. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes., INTERNATIONAL JOURNAL OF CANCER, 115, 388-392, 20050401
  193. Somatic mutations of mitochondrial DNA in digestive tract cancers, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 20(11), 1679-1684, NOV 2005
  194. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 130(5), 259-265, MAY 2004
  195. ADAM8 as a novel serological and histochemical marker for lung cancer, CLINICAL CANCER RESEARCH, 10(24), 8363-8370, DEC 15 2004
  196. Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review, JOURNAL OF CLINICAL PATHOLOGY, 57(4), 428-431, APR 1 2004
  197. Characterization of vitamin D-mediated induction of the CYP 24 transcription, MOLECULAR AND CELLULAR ENDOCRINOLOGY, 226(1-2), 27-32, OCT 29 2004
  198. Chromosomal and microsatellite instability in sporadic gastric cancer, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 19(7), 756-760, JUL 2004
  199. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 25(3), 579-595, SEP 2004
  200. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 112(6), 1003-1009, DEC 20 2004
  201. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma, VIRCHOWS ARCHIV, 444(4), 324-331, APR 2004
  202. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma, CANCER RESEARCH, 64(2), 523-529, JAN 15 2004
  203. Expression of RhoC is associated with metastasis of gastric carcinomas, PATHOBIOLOGY, 71(1), 19-25, 2004
  204. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2N-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil, ONCOLOGY REPORTS, 11(1), 9-15, JAN 2004
  205. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 110(2), 212-218, JUN 10 2004
  206. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma, PATHOBIOLOGY, 71(3), 137-143, 2004
  207. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression, CANCER RESEARCH, 64(7), 2397-2405, APR 1 2004
  208. High molecular weight caldesmon positive stromal cells in the capsule of hepatocellular carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(7), 776-777, JUL 2004
  209. Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(2), 183-185, FEB 1 2004
  210. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality, ONCOLOGY REPORTS, 12(5), 985-990, NOV 2004
  211. Meeting Report "New approaches to identification of biomarkers for early cancer detection": The Thirteenth International Symposium of the Hiroshima Cancer Seminar, October 2003, CANCER SCIENCE, 95, 193-195, 20040401
  212. Molecular-pathological prognostic factor of gastric cancer: a review, GASTRIC CANCER, 8, 86-94, 20040401
  213. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implication, CANCER SCIENCE, 95, 385-392, 20040401
  214. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications, CANCER SCIENCE, 95(5), 385-392, MAY 2004
  215. Single nucleotide polymorphism in the hypoxia-inducible factor-1 alpha gene in colorectal carcinoma, ONCOLOGY REPORTS, 12(5), 1033-1037, NOV 2004
  216. A possible role for the loss of CD27-CD70 interaction in myelomagenesis, BRITISH JOURNAL OF HAEMATOLOGY, 120(2), 223-234, JAN 2003
  217. A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 107(4), 593-596, NOV 20 2003
  218. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan, INTERNATIONAL JOURNAL OF ONCOLOGY, 23(2), 421-427, AUG 2003
  219. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma, CANCER SCIENCE, 94(8), 692-698, AUG 2003
  220. DNA methylation of multiple genes in gastric carcinoma: Association with histological type and CpG island methylator phenotype, CANCER SCIENCE, 94(10), 901-905, OCT 2003
  221. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma, VIRCHOWS ARCHIV, 442(2), 118-123, FEB 2003
  222. Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma, VIRCHOWS ARCHIV, 443(2), 146-151, AUG 2003
  223. Expression of theTSP-1 gene and its association with promoter hypermethylation in gastric carcinomas, ONCOLOGY, 64, 423-429, 20030401
  224. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma, VIRCHOWS ARCHIV, 442(6), 563-568, JUN 2003
  225. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 311(4), 809-814, NOV 28 2003
  226. Helicobactor pylori infection is closely associated with telomere reduction in gastric mucosa, ONCOLOGY, 65(3), 275-282, 2003
  227. Histone acetylation and gastrointestinal carcinogenesis, ANN NY ACADEMY OF SCIENCE, 983, 220-231, 20030401
  228. Hypoxia-inducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance, CARCINOGENESIS, 24(11), 1779-1783, NOV 2003
  229. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells, ANTICANCER RESEARCH, 23(1A), 267-273, JAN-FEB 2003
  230. Molecular targeting therapy for cancer: the twelfth international symposium of the Hiroshima cancer seminar November 2002, CANCER SCIENCE, 94(2), 221-223, 20030201
  231. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 22(4), 773-778, APR 2003
  232. Promoter methylation of cyclin D2 gene in gastric carcinoma, INTERNATIONAL JOURNAL OF ONCOLOGY, 23(6), 1663-1670, DEC 2003
  233. Rapid and preferential induction of ATF3 transcription in response to low doses of UVA light, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 310(4), 1168-1174, OCT 31 2003
  234. Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma, ONCOLOGY, 64(4), 423-429, 2003
  235. Small cell carcinoma of the extrahepatic bile duct: Case report and immunohistochemical analysis, PATHOLOGY INTERNATIONAL, 53(12), 887-891, DEC 2003
  236. The promoter methylation status of the DNA repair gene O-6-methylguanine-DNA methyltransferase in ulcerative colitis, VIRCHOWS ARCHIV, 443(4), 518-523, OCT 2003
  237. Acetylated histone h4 is reduced in human gastric adenomas and carcinomas, JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 21(3), 377-382, SEP 2002
  238. Chromatin and Cancer: The eleventh international symposium of the Hiroshima Cancer Seminar., JAPANESE JOURNAL OF CANCER RESEARCH, 93, 467-469, 20020401
  239. Distinct promoter hypermethylation of p16(INK4a), CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas, JOURNAL OF PATHOLOGY, 198(1), 55-59, SEP 2002
  240. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues, ANTICANCER RESEARCH, 22(6C), 4101-4107, NOV-DEC 2002
  241. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer, JOURNAL OF PATHOLOGY, 196(2), 163-170, FEB 2002
  242. Increased expression of Chk2 in human gastric carcinomas harboring p53 mutations, INTERNATIONAL JOURNAL OF CANCER, 99(1), 58-62, MAY 1 2002
  243. Induction of hRAD9 is required for G2/M checkpoint signal transduction in gastric cancer cells, PATHOBIOLOGY, 70(1), 40-46, 2002
  244. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas, INTERNATIONAL JOURNAL OF CANCER, 102(3), 220-224, NOV 20 2002
  245. No mutations of the Bub1 gene in human gastric and oral cancer cell lines, ONCOLOGY REPORTS, 9(6), 1229-1232, NOV-DEC 2002
  246. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa, EUROPEAN JOURNAL OF CANCER, 38(10), 1413-1419, JUL 2002
  247. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas, INTERNATIONAL JOURNAL OF CANCER, 93(5), 662-666, SEP 1 2001
  248. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas, ONCOLOGY REPORTS, 8(5), 1085-1089, SEP-OCT 2001
  249. Epithelial-myoepithelial carcinoma of the parotid gland with adenoid cystic carcinoma-like features: a case report with immunohistochemical study, Hiroshima J. Med. Sci., 50, 101-104, 20010401
  250. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas, PATHOBIOLOGY, 69(1), 24-29, 2001
  251. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas, PATHOBIOLOGY, 69(4), 219-224, 2001
  252. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19(3), 507-512, SEP 2001
  253. Expression of TRF1 (telomeric repeat binding factor 1 and 2) and TIN2 (TRF1-interacting nuclear protein 2) in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 507-512, 20010401
  254. Genetic and epigenetic changes in stomach cancer, INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 204, 204, 49-95, 2001
  255. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3, CLINICAL CANCER RESEARCH, 7(12), 4067-4072, DEC 2001
  256. Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer, DIFFERENTIATION, 68(1), 13-21, AUG 2001
  257. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas, PATHOBIOLOGY, 69(6), 315-320, 2001
  258. Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells, PROSTATE, 49(1), 19-29, SEP 15 2001
  259. Interleukin-15 expression is associated with malignant potential in colon cancer cells, PATHOBIOLOGY, 69(2), 86-95, 2001
  260. Meeting Report"Gene Diagnosis-Introduction of New Technology" : The Tenth International Symposium of the Hiroshima Cancer Seminar, October 2000(共著), JAPANESE JOURNAL OF CANCER RESEARCH, 92, 239-242, 20010401
  261. Molecular diagnosis of gastric cancer: present and future, GASTRIC CANCER, 4, 113-121, 20010401
  262. No mutations of the Bub1 gene in human gastric carcinomas, ONCOLOGY REPORTS, 8(4), 791-794, JUL-AUG 2001
  263. Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 92(1), 42-50, JAN 2001
  264. Pleomorphic adenoma of the parotid gland with extensive bone formation, PATHOLOGY INTERNATIONAL, 51(11), 883-886, NOV 2001
  265. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 93(6), 805-809, SEP 15 2001
  266. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa, PATHOBIOLOGY, 69(3), 143-149, 2001
  267. Prostpective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis, JOURNAL OF EXPERIMENTAL AND CLINICAL CACER RESEARCH, 20(4), 543-548, 20010401
  268. Proton pump inhibitors reduce cell cycle abnormalities in Barrett’s esophagus, ONCOGENE, 20, 7987-7991, 20010401
  269. The promoter methylation status of the DNA repair genes, hMHL1 and MGMT, in gastric carcinoma and metaplastic mucosa, PATHOBIOLOGY, 69, 143-149, 20010401
  270. A case of calcium pyrophosphate dihydrate crystal deposition in the knee joint with synovial osteochondromatosis, JOURNAL OF TRANSPORTATION MEDICINE, 54, 93-96, 20000401
  271. Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas, EUROPEAN JOURNAL OF CANCER, 36(8), 1002-1007, MAY 2000
  272. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis, CANCER LETTERS, 149(1-2), 125-134, FEB 28 2000
  273. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines, CANCER LETTERS, 151(2), 199-208, APR 14 2000
  274. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines, INTERNATIONAL JOURNAL OF CANCER, 88(6), 992-997, DEC 15 2000
  275. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: Association with Helicobacter pylori infection, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 5(2), 185-190, FEB 2000
  276. Helicobactor pylori infection and carcinogenesis of the stomach, LANGENBECKS ARCHIVES OF SURGERY, 385(2), 69-74, MAR 2000
  277. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues, ONCOGENE, 19(34), 3888-3893, AUG 10 2000
  278. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer, AMERICAN JOURNAL OF PATHOLOGY, 157(5), 1523-1535, NOV 2000
  279. Meeting Report ’Pediatric Tumors and Secondary Cancer. The Ninth International Symposium of the Hiroshima Cancer Seminar, September 1999, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 126, 357-359, 20000401
  280. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus, ANTICANCER RESEARCH, 20(1A), 213-217, JAN-FEB 2000
  281. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8, CLINICAL CANCER RESEARCH, 6(7), 2735-2740, JUL 2000
  282. Trichostatin A inhibits cell growth and modulate expression of cell cycle- and apoptosis-related molecules in human gastric and oral cancer cell lines, INTERNATIONAL JOURNAL OF CANCER, 1, 992-997, 20000401
  283. Abnormalities in the expression cell cycle related proteins in tumors of the small bowel, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 8, 1101-1105, 19990401
  284. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype, INTERNATIONAL JOURNAL OF CANCER, 83, 192-196, 19990401
  285. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 255, 753-758, 19990401
  286. Evidence for the causal role of IL-8 in angiogenesis and tumorigenecity of human gastric carcinoma cells, BRITISH JOURNAL OF CANCER, 81, 647-653, 19990401
  287. EXPRESION OF THE E2F FAMIRY IN HUMAN GASTROINTEST INAL CARCINOMAS, INTERNATIONAL JOURNAL OF CANCER, 81, 535-538, 19990101
  288. Expression of cell cycle regulating transcription factor E2F-1 in colorectal carcinomas, PATHOBIOLOGY, 67, 174-179, 19990401
  289. Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma, ONCOLOGY REPORTS, 6, 983-987, 19990401
  290. Expression of the E2F family in human gastrointestinal carcinomas, INTERNATIONAL JOURNAL OF CANCER, 81, 535-538, 19990401
  291. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections, ONCOGENE, 18(8), 1561-1567, 19990401
  292. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach, JAPANESE JOURNAL OF CANCER RESEARCH, 90(6), 589-595, 19990401
  293. Meeting Report ’Aging and cancer’. The Eighth International Symposium of the Hiroshima Cancer Seminar, November 1998, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 125, 375-377, 19990401
  294. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology, PATHOLOGY INTERNATIONAL, 49(9), 763-774, 19990401
  295. No mutations of the Smad2 gene in human sporadic gastric carcinomas, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 29, 3-7, 19990401
  296. Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis, VIRCHOWS ARCHIV, 434, 483-487, 19990401
  297. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues, MOLECULAR CARCINOGENESIS, 26(4), 312-320, 19990401
  298. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 in oral malignant tumors, PATHOBIOLOGY, 67, 169-173, 19990401
  299. Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line, JAPANESE JOURNAL OF CANCER RESEARCH, 90(5), 485-489, 19990401
  300. Subcutaneous leiomyoma arising from the srteriole: case report, JOURNAL OF TRANSPORTATION MEDICINE, 53, 80-82, 19990401
  301. Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions, Eur J Gynaecol Oncol, 19, 316-318, 19980401
  302. Co-expression of osteopontin and CD44v9 in gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 79, 127-132, 19980401
  303. Expression of CD44 containing variant exon 9(CD44v9) in gastric adenomas and adenocarcinomas: Relation to the proliferation and progression., INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 1253-1258, 19980401
  304. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 89(11), 1099-1103, 19980401
  305. Expression of vascular endothelial growth factor in human gastric carcinomas, PATHOLOGY INTERNATIONAL, 48, 499-506, 19980401
  306. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 1245-1251, 19980401
  307. Frequent p53 gene mutations in serrated adenomas of the colorectum, JOURNAL OF PATHOLOGY, 186, 131-139, 19980401
  308. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions, JAPANESE JOURNAL OF CANCER RESEARCH, 89(11), 1187-1194, 19980401
  309. Meeting Report ’Gene therapy : Application to disease’. The Seventh International Symposium of the Hiroshima Cancer Seminar, November 1997, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 124, 285-287, 19980401
  310. Microsatellite Instability Associated with Primary Head and Neck Cancers and Secondary Esophageal Cancers, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 28(12), 733-739, 19981201
  311. nm23 expression in carcinoma of the uterine cervix, Eur J Gynaecol Oncol, 19, 312-315, 19980401
  312. nm23 protein expression in renal cell tumors: the role of the cell type, ONCOLOGY REPORTS, 5, 979-983, 19980401
  313. Reduced Expression of Cyclin-dependent Kinase Inhibitor p27Kip1 is an Indicator of Malignant Behavior of Oral Squamous Cell Carcinomas, CANCER, 83, 2447-2466, 19980401
  314. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis, JOURNAL OF ORAL APTHOLOGY AND MEDICINE, 27, 197-201, 19980401
  315. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers, JOURNAL OF CLINICAL PATHOLOGY, 50, 841-846, 19970401
  316. Expression of human telomerase RNA is an early event of stomach carcinogenesis, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 103-107, 19970401
  317. Expression of Interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 953-958, 19970401
  318. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. 「(共著)」, PATHOLOGY INTERNATIONAL, 47, 470-477, 19970401
  319. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein, DIFFERENTIATION, 61, 313-320, 19970401
  320. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27(Kip1) in a human gastric carcinoma cell line, CELL GROWTH AND DIFFERENTIATION, 8(1), 47-52, 19970401
  321. Growth stimulatory effect of interleukin (IL)-1a produced by oral squamous carcinoma cell lines., INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 807-812, 19970401
  322. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 genes in Japanese hereditary nonpolyposis colorectal cancer kindreds, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 6, 1057-1064, 19970401
  323. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa, Digestive Diseases Sci, 42, 1199-1209, 19970401
  324. Overexpression of CDK-activating CDC25B phosphatase in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 947-952, 19970401
  325. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 625-629, 19970401
  326. A case of hepatoblastoma in an adult associated with c-met proto-oncogene imbalance, PATHOLOGY INTERNATIONAL, 46, 1005-1010, 19960401
  327. Expression of cripto in human gall bladder lesions, JOURNAL OF PATHOLOGY, 180, 166-168, 19960401
  328. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines, JOURNAL OF EXPERIMENTAL AND THERAPEUTIC ONCOLOGY, 1, 7-12, 19960401
  329. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein, VIRCHOWS ARCHIV, 429, 13-19, 19960401
  330. Expression of cyclin E in human gastric adenomas and adenocarcinomas: Correlation with proliferative activity and p53 status, JOURNAL OF EXPERIMENTAL AND THERAPEUTIC ONCOLOGY, 1, 88-94, 19960401
  331. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach : Relation with p53 status and proliferative activity, JOURNAL OF PATHOLOGY, 180, 122-128, 19960401
  332. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 87(8), 824-830, 19960401
  333. High frequency of p53 gene mutations in adenocarcinomas of the gallbladder, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 5, 461-466, 19960401
  334. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells, JAPANESE JOURNAL OF CANCER RESEARCH, 87(4), 377-384, 19960401
  335. Meeting Report ’Telomerase and cancer. The Fifth International Symposium of Hiroshima Cancer Seminar, October 1995, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 122, 770-773, 19960401
  336. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach, CANCER, 77/8S, 1620-1627, 19960401
  337. Molecular diagnosis of gastrointestinal cancers: The applications to clinical practice, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 1, 63-68, 19960401
  338. No point mutations but a codon 31 polymorphism and decreased expression of p21SDI1/WAF1/CIP1/MDA6 gene in human gastric carcinomas, MOLECULAR AND CELLULAR DIFFERENTIATION, 4, 187-198, 19960401
  339. A case of fetal epidural hematoma caused by a slight car collision and liability for the fatality, Res. Pract. Forens. Med., 38, 231-234, 19950401
  340. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study, BRITISH JOURNAL OF CANCER, 72, 976-980, 19950401
  341. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas, INTERNATIONAL JOURNAL OF CANCER, 62, 25-28, 19950401
  342. Expression of amphiregulin in human gastric cancer cell lines, CANCER, 75, 1460-1466, 19950401
  343. Expression of IL-6 and its effect on the cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 953-958, 19970401
  344. Expression of Stat91, Ras-independent signal transducer and activator, in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 7, 907-911, 19950401
  345. Frequent amplification of the cycin E gene in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 86, 617-621, 19950401
  346. IL-1αin produced by oral squamous carcinoma cell lines and stimulates their growth, ORAL ONCOLOGY, 4, 324-327, 19950401
  347. Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas, VIRCHOWS ARCHIV, 426(4), 355-359, 19950501
  348. Increased expression and posphorylatioln of SH-PTP2 (SYP) in human gastric carcinolmas, ONCOLOGY REPORTS, 2, 819-823, 19950401
  349. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions, CLINICAL CANCER RESEARCH, 1(11), 1245-1251, 19950401
  350. Alterations and expression of bcl-2 gene in human gastric and colonic carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 85, 584-591, 19940401
  351. Coamplification of cyclin D, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas., ONCOLOGY REPORTS, 1, 493-496, 19940401
  352. Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines, VIRCHOWS ARCHIV, 425, 139-144, 19940401
  353. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 56, 474-480, 19940401
  354. Expression of cripto in human gastric carcinomas : an association with tumor stage and prognosis, JOURNAL OF EXPERIMENTAL AND CLINICAL CACER RESEARCH, 13, 151-157, 19940401
  355. Expression of cripto in human pancreatic tumors, JAPANESE JOURNAL OF CANCER RESEARCH, 85, 118-121, 19940401
  356. Expression of β1 integrin in human gastric carcinomas : correlation with histological type and tumor progression, INTERNATIONAL JOURNAL OF ONCOLOGY, 5, 225-230, 19940401
  357. Frequent loss of heterozygosity of chromosome 7q is closely associated with progression of human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 59, 597-600, 19940401
  358. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers, CANCER RESEARCH, 54, 3373-3375, 19940401
  359. Gene alterations in intestinal metaplasia and gastric cancer, Eur J Gastroenterol Hepatol, 6, 97-101, 19940401
  360. Meeting Report ’The First International Workshop of the Princess Takamatsu Cancer Research Fund: Intestinal metaplasia and gastric cancer’, MOLECULAR CARCINOGENESIS, 11, 1-7, 19940401
  361. Meeting Report ’Tumor suppressor gene, TheThird International Symposium of Hiroshima Cancer Seminar, Hiroshima, Japan, October 1993’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 120, 615-619, 19940401
  362. A case of death after trichloroethylene sniffing and a fight, Jpn. J Forensic Toxicol., 11, 187-193, 19930401
  363. Aberrant expression of c-met mRNA in human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 72-75, 19930401
  364. Biologic effect of hepatocyte growth factor on human gastric carcinoma cell lines, INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 89-93, 19930401
  365. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 84, 879-884, 19930401
  366. Expression of growth factors and their receptors in human esophageal carcinomas:regulation of expresion by EGF and TGF-alpha., JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 401-407, 19930401
  367. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression, INTERNATIONAL JOURNAL OF CANCER, 54, 49-52, 19930401
  368. GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines, CELL GROWTH AND DIFFERENTIATION, 4, 291-296, 19930401
  369. IL-1a acts as an autocrine growth stimulator for human gastric carcinoma cells, CANCER RESEARCH, 53, 4102-4106, 19930401
  370. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas, INTERNATIONAL JOURNAL OF CANCER, 53, 36-41, 19930401
  371. Interleukin 1a acts as an autocrine growth stimulator for human gastric carcinoma cells, CANCER RESEARCH, 53, 4102-4106, 19930401
  372. Meeting Report ’Carcinogenesis and metastasis, The second international symposium of Hiroshima Cancer Seminar, Hiroshima, Japan, June 1992’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 560-563, 19930401
  373. Occifying fibromyxoid tumor of soft parts : A case report, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 23, 64-68, 19930401
  374. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 84, 184-190, 19930401
  375. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 63, 213-218, 19930401
  376. Reduced tumorigenicity and cell motility of a gastric carcinoma cell line by introduction of wild-type p53 gene, INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 265-271, 19930401
  377. A serine protease inhibitor of benzamidine derivative inhibits the growth of human colon carcinoma cells, JAPANESE JOURNAL OF CANCER RESEARCH, 83, 723-728, 19920401
  378. Expression of transforming growth factor alpha in human tissue : immunohistochemical study and Northern blot analysis, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 421, 513-519, 19920401
  379. Frequent amplification and expression of the c-met gene in human scirrhous type stomach cancer, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 189, 227-232, 19920401
  380. Genetic abnormalities and expression of p53 in human colon carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 1, 431-437, 19920401
  381. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells : Receptor and postreceptor signaling, CANCER RESEARCH, 52, 295-300, 19920401
  382. p53 gene mutations in gastric cancer cell lines, ONCOLOGY (Life Sci Adv), 11, 7-12, 19920401
  383. p53 point mutations in primary human gastric carcinomas, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 67-70, 19920401
  384. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 83, 86-92, 19920401
  385. The level of transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 189, 1342-1348, 19920401
  386. Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinomas, PATHOLOGY RESEARCH AND PRACTICE, 188, 37-43, 19920401
  387. Effect of tyrosine kinase inhibitor, erbstatin, on cell growth and growth factor/recptor expression in human gastric carcinoma cells, INTERNATIONAL JOURNAL OF CANCER, 47, 938-942, 19910401
  388. Express of cripto a novel gene of the epidermal growth factor family,in human gastrointestinal carcinomas., JAPANESE JOURNAL OF CANCER RESEARCH, 821, 963-973, 19910401
  389. Expression of basic fibroblast growth factor in human gastric carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 61, 263-267, 19910401
  390. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 82, 969-973, 19910401
  391. Expression of epidermal growth factor in human tissues : Immunohistochemical and biochemical analysis, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 418, 27-32, 19910401
  392. Inhibitory effect of 8-Chloro-cyclic adenosine 3',5'-monophosphate on cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 82, 325-331, 19910401
  393. Myxoid leiomyosarcoma of the stomach: A case report, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 21, 447-452, 19910401
  394. Depressed tubular adenoma of the stomach: Pathological and immunohisto- chemical properties, HISTOPATHOLOGY, 17, 419-426, 19900401
  395. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 58, 273-277, 19900401
  396. Effect of epidermal growth factor on rat stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine, ACTA PATHOL JPN, 40, 165-171, 19900401
  397. Expression of ERBB2 in human gastric carcinomas : Relationship between p185ERBB2 expression and the gene amplification, CANCER RESEARCH, 50, 8002-8009, 19900401
  398. Expression of several growth factors and their receptor genes in human colon carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 59, 173-178, 19900401
  399. Growth factors in progression of human esophageal and gastric carcinomas, EXPERIMENTAL PATHOLOGY, 291-300, 19900401
  400. pp60c-src protein kinase activity in human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 45, 847-851, 19900401
  401. Characterization of early DNA synthesis in Xenopus eggs after injection of circular plasmid DNA, NUCLEIC ACIDS RESEARCH, 17, 3709-3723, 19890401
  402. Effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1, Hiroshima J. Med. Sci., 38, 191-195, 19890401
  403. Minichromosome assembly accompanying repair-type DNA synthesis in Xenopus oocytes, NUCLEIC ACIDS RESEARCH, 17, 10243-10258, 19890401
  404. Presence of multiple species of polypeptides immunologically related to transcription factor TFIIIA in adult Xenopus tissues, NUCLEIC ACIDS RESEARCH, 17, 5597-5610, 19890401
  405. Quantitation and subcellular localization of proliferating cell nuclear antigen (PCNA/cyclin) on oocytes and eggs of Xenopus laevis, EXPRIMENTAL CELL RESEARCH, 182, 384-393, 19890401
  406. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas, CANCER RESEARCH, 48, 137-141, 19880401
  407. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 41, 211-217, 19880401
  408. Phenotypic expression of human epidermal growth factor in fetal submandibular gland and pleomorphic adenoma of salivary gland., VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 412, 301-306, 19880101
  409. Effects of a protein-free diet on the rat stomach, GASTROENTEROLOGY, 92, 1051-1059, 19870401
  410. Expression of Ha-ras oncogene product in rat gastrointestinal carcinomas induced by chemical carcinogens, ACTA PATHOL JPN, 37, 1731-1741, 19870401
  411. Immunohistochemical detection of c-myc-oncogene product in human gastric carcinomas: Expression in tumor cells and stromal cells, JAPANESE JOURNAL OF CANCER RESEARCH, 78, 1169-1174, 19870401
  412. Cholecystokinin inhibition of tumor growth and gastrin-stimulated cAMP metabolism in human gastric carcinoma in nude mice, CANCER RESEARCH, 46, 740-743, 19860401
  413. Gut endocrine cells in rat stomach carcinoma induced by N-methyl-N’-nitro-N-nitrosoguanidine, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 111, 87-92, 19860401
  414. Ha-ras oncogene product in human gastric carcinoma: Correlation with invasiveness, metastasis or prognosis, JAPANESE JOURNAL OF CANCER RESEARCH, 77, 517-522, 19860401
  415. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy, JAPANESE JOURNAL OF CANCER RESEARCH, 77, 145-152, 19860401
  416. Light and electron microscopic observations of the white pulp of the dog spleen during hemorrhagic shock, PATHOLOGY RESEARCH AND PRACTICE, 181, 586-595, 19860401
  417. Calcium-activated, phospholipid-dependent protein kinase in human gastric mucosa and carcinoma, JAPANESE JOURNAL OF CANCER RESEARCH, 76, 1168-1173, 19850401
  418. Effect of gastrin on gastric mucosal cyclic adenosine 3’:5’-monophosphate- dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine, CANCER RESEARCH, 45, 4763-4767, 19850401
  419. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1, JAPANESE JOURNAL OF CANCER RESEARCH, 76, 1064-1071, 19850401
  420. Type I and II cyclic adenosine3’:5’-monophosphate-dependent protein kinase in human gastric mucosa and carcinomas, CANCER RESEARCH, 45, 1565-1568, 19850401
  421. Effect of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric carcinoma in nude mice, CANCER RESEARCH, 44, 4276-4280, 19840401
  422. Secretory component and immunoglobulin in human gastric carcinoma: An immunohistochemical studySecretory component and immunoglobulin in human gastric carcinoma: An immunohistochemical study, JAPANESE JOURNAL OF CANCER RESEARCH, 75, 166-176, 19840401

Publications such as books

  1. 2017/02, Standard Text Book PT/OT Pathology 4th ed., 8 Neoplasia, Igakushoin, 2017, 2017, Japanese, 978-4-260-02871-4, 295, 19
  2. 2015/08/15, Simple Pathology 7th ed., Nankodo, 2015, 8, Japanese, Hironobu Sasano, Yasunori Okada, Wataru Yasui, ISBN978-4-524-26154-3C3047, 394, 394
  3. 2014, Atlas of Gastric Cancer Pathology for Clinician, Medical Review Co., 2014, 08, Japanese, Wataru Yasui, Masaki Kitajima, Kazuhiro Yoshida, 143, 143
  4. 2014, Master of Gastric Surgery, Handling of surgically resected specimen in pathology, Medical View Co. Ltd., 2014, 201403, Japanese, Kasuhiro Sentani, 978-4-7583-1514-2 C3047
  5. 2013, Principle of molecular diagnostics and personalized cancer medicine, Lippincott Williams & Wilkins, 2013, Yasui W, Oue N, Sentani K, Tan DF
  6. 2012, Clinical Radiation Oncology, Tumor biology, Nankodo Co., 2012, 201212, 26322-6 C3047
  7. 2012/, , Handbook on Effect of A-bomb Radiation, 2nd ed., Effects on human body, Bunkodo Co. Ltd., 2012, 3, Japanese, 978-4-8306-3741-4 C3047
  8. 2011, Radiation Exposure and Thyroid Cancer - Hiroshima, Chernobyl and Semipalatinsk, Keisuisha Co., 2011, Japanese, Takeishi N, Hosi M, Yasui W, 978-4-86327-152-4 C3047, 141
  9. 2010, Scirrhous Carcinoma of the Stomach - A Multidisciplinary Approach, Genetic alterations in scirrhous type gastric cacner, Ishiyaku Journal Co. Ltd., 2010, 3, Japanese, Wataru Yasui, Junichi Motoshita, Naohide Oue, 978-4-7532-2429-6 C3047
  10. 2010, Atlas - Cytological and Pathological Diagnosis, Igakushoin Co.Ltd., 2010, 6, Japanese, Wataru Yasui, 978-4-260-00941-6 C3047
  11. 2010, Dynamic Pathology, Nishimura Co. Ltd., 2010, 12, Japanese, Nayakama F, Yasui W, 978-4-89013-402-1 C3047
  12. 2009, Histological and serological tumor markers and their clinical usefulness in cancers, Nova Science Publishers, 2009, Yasui W, Sentani K, Sakamoto N, Motoshita J, Oue N
  13. 2007, International Congress Series: Radiation Risk Perspectives , Elsevier Science Publishers, 2007, 05, Yasui W
  14. 2006, Recent advances in molecular pathobiology of gastric carcinoma. , 2006, 04, Yasui W, Oue n, Kitadai Y, Nakayama H, 51
  15. 2005, The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy , Springer-Verlag, 2005, Yasui W, Oue N, Kitadai Y, Nakayama H
  16. 2003, Handbook of Experimental Pharmacology Mechanisms in Carcinogenesis and Cancer Research , Springer-Verlag, 2003, Ohgaki H, Yasui W, Yokota J
  17. 1999, Molecular Pathology of Early Cancer , IOS press, 1999, Yasui W
  18. 1997, Molecular Pathology of Gastrointestinal Cancer -Application to Clinical Practice- , Springer-Verlag, 1997, Yasui W
  19. 1996, Cell Proliferation in Cancer , Oxford University Press, 1996, Yasui W
  20. 1996, The Chernobyl Accident. Thyroid Abnormalities in Children, Congenital Abnormalities and Other Radiation Related Information - The First Ten Years - , Hiroshima-Nagasaki Peace Foundation, 1996, Yasui W
  21. 1994, Gann Monograph on Cancer Research No. 42, Growth factors: cell growth, morphogenesis, and transformation , CRC Press, 1994, Yasui W
  22. 1993, Surgical Gynecologic Oncology , Georg Thime Verlag, 1993, Yasui W
  23. 1993, Gastric Cancer , Springer-Verlag, 1993, Yasui W
  24. 1992, Diagnostic Molecular Pathology Vol. II: A Practical Approach , IRL Press= Oxford University Press, 1992, Yasui W
  25. 1988, Progress in Cancer Research and Therapy, Hormone and Cancer 3 , Raven Press Ltd, 1988, Yasui W

Invited Lecture, Oral Presentation, Poster Presentation

  1. Message from Japanese Gastric Cancer Association - Cross-disciplinary approach to control gastric cancer in precision medicine, Wataru Yasui, The 2016 Annual Congress of Korean Surgical Society, 2016/11/03, With Invitation, Seoul (Korea)
  2. Significance of KIF Genes in Gastric Spheroid Formation, Oue N, Imai T, Yasui W, The 3rd International Forum for Japan and Korea Medical Exchange, 2016/10/15, With Invitation
  3. Molecular pathological appreoach to develop novel cancer diagnostics and therapeutics, Wataru Yasui, The 27th Annual Meeting of the Japanese Society of Oral Pathology, 2016/08/12, With Invitation, Hiroshima (Japan)
  4. Identification of diagnostic and therapeutic targets of gastroesophageal cancer, Wataru Yasui, GAP-related meeting between Hiroshima University and the University of Texas MD Anderson Cancer Center, 2016/07/21, With Invitation, Hiroshima (Japan)
  5. Identification of diagnostic and therapeutic targets of gastroesophageal cancer, Wataru Yasui, GAP-related meeting between Hiroshima University and the University of Texas MD Anderson Cancer Center, 2016/07/21, With Invitation
  6. Molecular Pathology of Gastrointestinal Cancer, Wataru Yasui, Special lecture at Hacettepe University, 2016/02/09, With Invitation, Ankara, Turkey
  7. Molecular pathology of gastric cancer, Wataru Yasui, The 2nd International Forum for Japan and Korea Medical Exchange, 2015/10/17, With Invitation, Kure (Japan)
  8. Pathological diagnosis using a virtual microscope, Taniyama D, Taniyama K, Kuraoka K, Zaitsu J, Saito A, Yasui W, National University Hospital of Singapore – MD Anderson Cancer Center Pathology Update 2015, 2015/10/15, Without Invitation, Singapore (Singapore)
  9. Molecular pathology of gastric cancer, Wataru Yasui, JP Kim Memorial International Gastric Cancer Symposium, 2015/07/31, With Invitation, Seoul, Korea
  10. Molecular pathology of gastric cancer, Wataru Yasui, JP Kim Memorial International Gastric Cancer Symposium, 2015/07/31, With Invitation
  11. Endoscopic management of early gastric cancer: Molecular analysis in endoscopic specimen, Wataru Yasui, The 11th International Gastric Cancer Congress, 2015/06, With Invitation, Sao Paulo, Brazil
  12. Functional analysis of extracellular vesicles as a novel regulatory agent of scirrhous type gastric cancer microenvironment, Naito Y, Yashiro M, Hirakawa K, Yasui W, Ochiya T, International Society for Extracellular Vesicles 2015, 2015/04/23, Without Invitation, Washington D.C. (USA)
  13. Significance of KIFC1 in spheroid formation of gastric cancer cells., Oue N, Mukai S, Pham TBT, Sentani K, Yasui W, AACR (American Association for Cancer Research) Annual Meeting 2015, 2015/04/18, Without Invitation, Philadelphia, Pennsylvania (USA)
  14. The expression of FKTN gene in gastric cancer related to radiation exposure: research on atomic bomb survivors, Trang T. Pham, Oue N, Yasui W, AACR (American Association for Cancer Research) Annual Meeting 2015, 2015/04/18, Without Invitation, Philadelphia, Pennsylvania (USA)
  15. Novel biomarkers and therapeutic targets of gastrointestinal cancer identified through transcriptome dissection, Wataru Yasui, The 2nd International Symposium of Hiroshima Research Center for Healthy Ageing, 2015/03, With Invitation, Higashi-Hiroshima
  16. Molecular pathology of cancer cell growth and progression in gastrointestinal cancer, Wataru Yasui, 2015 International Symposium on Tissue Microenvironmental Modulators, 2015/03, With Invitation, Tokyo, Japan
  17. The expression of FKTN gene in gastric cancer related to radiation exposure: research on atomic bomb survivors, Pham TBT, Oo HZ, Sentani K, Oue N, Yasui W, The 4th International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2015/02/14, Without Invitation, Hiroshima
  18. Molecular Pathology of Gastrointestinal Cancer: Identification of novel biomarkers through transcriptome dissection, Wataru Yasui, Special lecture at Federation of Turkish Pathology and Ankara Pathology Society, 2015/02/11, With Invitation, Ankara, Turkey
  19. Relation of Inflammation and neoangiogenesis of epicardial adipose tissue to coronary atherosclerosis based on computed tomography analysis, Tsushima H, Kitagawa T, Yamamoto H, Sentani K, Yasui W and Kihara Y, Scientific Sessions 2014 of American Heart Association, 2014/11/15, Without Invitation, Chicago, Illinoi (USA)
  20. Sulindac delayed and suppressed tumor progression in a human colorectal cancer mouse model (CPC;APC mouse), Adachi T, Hinoi T, Sasaki Y, Shimomura M, Saito Y, Miguchi M, Niitsu H, Kouchi M, Oue N, Yasui W and Ohdan H, The 8th International Conference of the International Society of Gastroenterological Carcinogenesis, 2014/11/13, With Invitation
  21. Significance of spheroid formation associated genes in gastric cancer, Oue N, Mukai S, Trang Pham TB, Sentani K, Yasui W, The 8th International Conference of the International Society of Gastroenterological Carcinogenesis, 2014/11/13, With Invitation
  22. Fukutin, identified by Escherichia coli Ampicillin Secretion Trap (CAST) method, participates in tumor progression in gastric cancer, Sentani K, Oo HZ, Shinmei S, Mukai S, Sakamoto N, Naito Y, Goto K, Hattori Y, Uraoka N, Oue N and Yasui W, The 5th Taiwan-Japan Conjoint Slide Conference of IAP, 2014/10/25, Without Invitation, Taipei (Taiwan)
  23. Novel biomarkers and therapeutic targets for gastric cancer, Wataru Yasui, The 7th Annual Scientific Meeting of the Singapore Gastric Cancer Consortium, 2014/07, With Invitation, Singapore
  24. Regenerating islet-derived family, member 4 enhances cell proliferation, castration-resistance, and chemoresistance through acceleration of neuroendocrine differentiation in human prostate cancer cells., Teishima J, Shoji K, Goto K, Ryoken Y, Shikuma H, Nagatsuma H, Shinmei S, Kitano H, Ohara S, Hayashi T, Oue N, Yasui W and Matsubara A, Annual Meeting of the American Urological Association 2014,, 2014/05/16, Without Invitation, Orland, Florida (USA)
  25. Regenerating islet-derived family, member 4 enhances cell proliferation, castration-resistance, and chemoresistance through acceleration of neuroendocrine differentiation in human prostate cancer cells, Teishima J, Shoji K, Goto K, Ryoken Y, Shikuma H, Nagatsuma H, Shinmei S, Kitano H, Ohara S, Hayashi T, Oue N, Yasui W and Matsubara A, 29th Annual Congress of the European Association of Urology, 2014/04/11, Without Invitation, Stockholm (Sweden)
  26. Sulindac delayed and suppressed the tumor progression, was not effective on inhibition of tumor initiation in a human colorectal cancer mouse model (CPC;Apc mouse), Adachi T, Hinoi T, Sasaki Y, Shimomura M, Saito Y, Miguchi M, Niitsu H, Sotomura Y, Oue N, Yasui W and Ohdan H, The 105th Annual Meeting of the American Association for Cancer Research, 2014/04/05, Without Invitation, San Diego, California (USA)
  27. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intrsepithelial lesion, Sakane J, Taniyama K, Miyamoto K, Sentani K, Oue N and Yasui W, The 105th Annual Meeting of the American Association for Cancer Research, 2014/04/05, Without Invitation, San Diego, California (USA)
  28. The utility of microRNA expression as a potential marker for radiation-associated gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani Km Oue N and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima
  29. Identification of ZDHHC14 by CAST method and its significance in scirrhous-type gastric cancer, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Oshima T, Yanagihara K and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima
  30. Relationship between FKTN gene expression in gastric cancer and radiation exposure of atomic bomb survivors, Pham TBT, Oo HZ, Sentani K, Hattori T, Mukai S, Uraoka N, Oue N and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima (Japan)
  31. ZDHHC14, identified by CAST method, is a putative regulator for peritoneal dissemination of scirrhous-type gastric cancer, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Oshima T, Yanagihara K, Yasui W, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  32. Role of microRNA-143 and its potential of prognostic factor in scirrhous type gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N and Yasui W, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  33. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Yasui W, Yoshikawa T, Rino Y, Kunisaki C, Imada T and Masuda M, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  34. Combining molecular target drugs to inhibit cancer-stromal cell interaction in gastric cancer, Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S, Yasui W and Chayama K, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  35. Novel biomarkers and therapeutic targets of gastric cancer, Wataru Yasui, The 4th JCA-AACR Special Joint Conference: The Latest Advances in Gastric Cancer Research, 2013/12, With Invitation, Chiba (Japan)
  36. Expression analysis of novel biomarkers identified by Escherichia coli ampicillin secretion trap: Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer, Goto K, Hayashi T, Shinmei S, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A and Yasui W, The 33rd Congress of the International Society of Urology, 2013/09/08, Without Invitation, Vancouver (Canada)
  37. A possible therapeutic agent for pulmonary fibrosis: antibody against integrin a8b1, Nishimichi N, Sentani K, Kanno K, Yausi W and Yokosaki Y, European Respiratory Society Annual Meeting 2013, 2013/09/07, Without Invitation, Barcelona (Spain)
  38. miR-148a, down-regulated in gastric cancer, targets MMP7 and participates in tumor invasion and poor prognosis, Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oo HZ, Yanagihara K, Aoyagi K, Sasaki H and Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, Without Invitation, Verona (Italy)
  39. Imada T and Masuda M: Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Sato T, Cho H, Yukawa N, Yoshikawa T, Rino Y, Kunisaki C, Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, Without Invitation, Verona (Italy)
  40. HP and carcinogenesis -Pathogenesis and novel diagnostic and therapeutic targets, Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, With Invitation
  41. HP and carcinogenesis -Pathogenesis and novel diagnostic and therapeutic targets, Wataru Yasui, 10th International Gastric Cancer Congress, 2013/06, With Invitation, Verona, Italy
  42. TSPAN8 expression in renal cell carcinoma is a poor prognostic factor and a novel therapeutic target, Hayashi T, Sentani K, Black PC, Goto K, Shinmei S, Teishima J, Anami K, Yasui W and Matsubara A, Annual Meeting of the American Urological Association 2013, 2013/05/04, Without Invitation, San Diego, California (USA)
  43. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Yoshikawa T, Rino Y, Kunisaki C, Yasui W, Imada T and Masuda M, 2013 ASCO Annual Meeting, 2013/04/31, Without Invitation, Chicago, Illinois (USA)
  44. SEC11A contributes to malignant progression through promotion of EGF and TGF-alpha secretion, Oue N, Hayashi T, Takigahara M, Nagatsuma A, Sentani K, Sakamoto N, Anami K, Uraoka N, Naito Y, Yanagihara K, Ochiai A, Sasaki H and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/04/06, Without Invitation, Washington D.C., Maryland (USA)
  45. ZDHHC14, a potential regulator of peritoneal dissemination of scirrhous type gastric carcinoma, identified by CAST method, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Yanagihara K and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/04/06, Without Invitation, Washington D.C., Maryland (USA)
  46. Novel Biomarkers and therapeutic targets of scirrhous type stomach cancer, Wataru Yasui, Commemorative Symposium for the 2nd anniversary of SNUCH, 2013/04, With Invitation, Seoul, Korea
  47. Differential expression and identification of novel genes in scirrhous type gastric cancer, by CAST method, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Yanagihara K and Yasui W, The 2nd International Symposium Phoenix Leader Education Program (Hiroshima Initiative) for Renaissance from Radiation Disaster, 2013/02/11, Without Invitation, Hiroshima (Japan)
  48. The utility of miR-143/miR-145 cluster as a potential marker for radiation-associated gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N and Yasui W, The 2nd International Symposium Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2013/02/10, Without Invitation, Hiroshima (Japan)
  49. Function of microRNA-143 and its potential of prognostic factor in scirrhous type gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N, Yashiro M, Hirakawa K and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/01/06, Without Invitation, Washington D.C., Maryland (USA)
  50. Novel biomarkers of gastric cancer identified by SAGE data analysis, Wataru Yasui, Korea-Japan Cancer Workshop on Gastric Cancer and Liver Cancer, 2012/11, With Invitation, Busan, Korea
  51. Molecular targets for diagnosis and therapeutics of gastric cancer - Present and future, Wataru Yasui, The 17th Japan-Korea Cancer Research Workshop, 2012/11, With Invitation, Busan, Korea
  52. Molecular pathology of gastric cancer - microRNA and novel diagnostic & therapeutic targets, Wataru Yasui, The 96th Annual Meeting of the German Society of Pathology, 2012/05, With Invitation, Berlin, Germany
  53. Transcriptome analysis of esophageal squamous cell carcinoma by SAGE identifies a new biomarker, NRD1, Uraoka N, Sakamoto N, Oue N, Sentani K, Anami K, Noguchi T, Yoshida K and Yasui W, The 103rd Annual Meeting of the American Association for Cancer Research, 2012/03/31, Without Invitation, Chicago, Illinois (USA)
  54. Mir-148a, down-regulated in gastric cancer, targets MMP and participates in tumor invasion, Sakamoto N, Naito Y, Sentani K, Oue N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  55. Identification of transmembrane protein in scirrhous type gastric cancer by the Escherichia coli ampicillin secretion trap method, Oo HZ, Sakamoto N, Anami K, Wakamatsu Y, Naito Y, Uraoka N, Sentani K, Oue N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  56. Upregulation of HOX10 in intestinal phenotype gastric cancer: Reduction during tumor progression and favorable prognosis, Sentani K, Oue N, Sakamoto N, Naito Y, Anami K, Oo HZ, Uraoka N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  57. Analysis of a novel transcriptional target: Reg IV is regulated by CDX2, Naito Y, Oue N, Sentani K, Sakamoto N, Anami K, Hayashi T, Uraoka N, Oo HZ and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  58. Molecular characteristics of gastric and intestinal phenotypes of gastric cancer, Wataru Yasui, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11, With Invitation, Hiroshima (Japan)
  59. Gene expression profile of scirrhous type gastric cancer analyzed by CAST method, Oo HZ, Uraoka N, Hayashi T, Anami K, Sakamoto N, Sentani K, Oue N and Yasui W, 8th International Symposium on Minimal Residual Cancer, 2011/09/21, Without Invitation, Osaka (Japan)
  60. Overexpression of SEC11A is associated with tumor progression through TGF-alpha secretion in gastric cancer, Oue N, Yanagihara K, Anami K, Sentani K, Sakamoto N, Naito Y and Yasui W, 8th International Symposium on Minimal Residual Cancer, 2011/09/21, Without Invitation, Osaka (Japan)
  61. Epigenetic alterations in colorectal cancer among atomic-bomb survivors, Ito R, Eguchi H, Hamatani K, Taga M, Oue N, Yasui W, Nakachi K and Kusunoki Y, Second AACR International Conference on Frontiers in Basic Cancer Research, 2011/09/14, Without Invitation, San Francisco, California (USA)
  62. Identification of novel diagnostic and therapeutic targets of gastric cancer by transcriptome dissection, Wataru Yasui, The Third CREAST - SBM International Conference "Mathematical Methods in Cancer Cell Biology", 2011/06, With Invitation, Hiroshima (Japan)
  63. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 2011 Annual Meeting of the American Urological Association, 2011/05/14, Without Invitation, Washington D.C. (USA)
  64. DSC2 is a new immunohistochemical marker indicative of squamous cell carcinoma component in urinary bladder cancer and a value of prognostic factor, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 2011 Annual Meeting of the American Urological Association, 2011/05/14, Without Invitation, Washington D.C. (USA)
  65. OLFM4 -a bacterial induced epithelial peptide in IBD downstream of Notch, Gersemann M, Becker S, Liu W, Oue N, Yasui W, Rodgers GP, Wehkamp J and Stange EF, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  66. Canonical Wnt signals promote intestinal stem cell proliferation in the native human colonic epithelium, Parris A, Scobioala-laker N, Reynolds A, Bigwood L, Mitchell EM, Lewis MP, Speakman CT, Wharton R, Hernon J, Sargen K, Kapur S, Oue N, Yasui W and Williams M, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  67. Compromised tissue renewal in the ageing human colonic epithelium., Mitchell EM, Parris A, Bigwood L, Scobioala-laker N, Reynolds A, Lewis MP, Leung W, Belshaw N, Johnson IT, Oue N, Yasui W, Beals I, Jamieson CP, Tremelling M, Tighe R, Prior A and Williams M, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  68. Gene expression profile in scirrhous type gastric mcancer by CAST method, Oo HZ, Uraoka N, Hayashi T, Anami K, Sakamoto N, Sentani K, Oue N and Yasui W, 9th International Gastric Cancer Congress, 2011/04/20, Without Invitation, Seoul (Korea)
  69. microRNA expression profiles in gastric cancer: miR-148a is down-regulated in gastric cancer and involved in gastric cancer invasion by repression of MMP7 expression, Sakamoto N, Naito Y, Uraoka N, Anami K, Sentani K, Oue N and Yasui W, 9th International Gastric Cancer Congress, 2011/04/20, Without Invitation, Seoul (Korea)
  70. Unique microRNA signatures associated with progression and prognosis of gastric cancer, Ueda T, Yasui W, Yoshida K, Sasaki S, Nomura S, Seto Y, Kaminishi M, Calin G, Croce C, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu C and Oue N, 9th International Gastric Cancer Congress,, 2011/04/20, Without Invitation, Seoul (Korea)
  71. DSC2 is a new immunohistochemical marker indicative of squamous cell carcinoma component in urinary bladder cancer and a value of prognostic factor, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 26th Annual Congress of the European Association of Urolo, 2011/04/02, Without Invitation, Vienna (Austria)
  72. Transcriptional regulation of REG4, a novel diagnostic marker of gastrointestinal cancer by CDX2, Naito Y, Oue N, Sentani K, Sakamoto N, Anami K, Hayashi T, Uraoka N, Oo HZ, Wakamatsu Y and Yasui W, The 102nd Annual Meeting of the American Association for Cancer Research, 2011/04/02, Without Invitation, Orland, Florida (USA)
  73. Blockade of PDFR signaling impairs the tumor promoting effect of bone marrow-derived mesenchymal stem cell in colon cancer., Shinagawa K, Kitadai Y, Ohnishi M, Ohara E, Tanaka M, Sumida T, Tanaka S, Yasui W and Chayama K, The 102nd Annual Meeting of the American Association for Cancer Research, 2011/04/02, Without Invitation, Orland, Florida (USA)
  74. Novel diagnostic and therapeutic targets of gastric cancer identified by "Omics" study, Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y and Oue N, 9th International Gastric Cancer Congress, 2011/04, With Invitation, Seoul (Korea)
  75. OLFM4 -a bacterial induced epithelial peptide in IBD downstream of Notch, Gersemann M, Becker S, Liu W, Oue N, Yasui W, Rodgers GP, Wehkamp J, Stange EF, 6th Congress of European Crohn's and Colitis Organization, 2011/02/24, Without Invitation, Dublin (UK)
  76. Analyses of novel genes encoding secreted and transmembrane proteins identified by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion, Hayashi T, Ohara S, Teishima J, Shoji K, Sentani K, Oue N, Yasui W and Matsubara A, Advancements in Urology 2011 an AUA/JUA Symposium, 2011/02/17, Without Invitation, Hawaii (USA)
  77. Molecular character of gastric and intestinal phenotypes of gastric cancer, Wataru Yasui, The 6th International Conference on Gastroenterological Carcinogenesis, 2011/01, With Invitation, Houston, USA
  78. Vessels constituting benign vascular lesions except arteriovenous hemangiomas lack vascular adventitial fibroblastic cells, Nakayama H, Enzan H and Yasui W, 56th Special Meeting of the Japanese Society of Pathology, International Poster Session, 2010/11/25, Without Invitation, Kokura (Japan)
  79. Mammary mucinous cystadenocarcinoma with ductal carcinoma in situ, Sentani K, Uraoka N and Yasui W, The 20th International Symposium of the Hiroshima Cancer Seminar, 2010/10/31, Without Invitation, Hiroshima (Japan)
  80. A study of central nervous system tumors by histological type in the Hiroshima Prefecture Tumor Registry, Tachiyama Y, Nishi N, Sugiyama H, Ozasa K, Arita K, Kamada N, Kajihara H and Yasui W, 32nd Annual Meeting of International Association of Cancer Registries, 2010/10/12, Without Invitation, Yokohama (Japan)
  81. Novel diagnostic and therapeutic targets of gastrointestinal cancer identified by Omics study, Wataru Yasui, The 9th International Conference of the Asian Clinical Oncology Society, 2010/08, With Invitation, Gifu (Japan)
  82. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis, Sentani K, Matsuda M, Anami K, Sakamoto N, Oue N and Yasui W, The 198th Scientific Meeting of the Pathological Society of Great Britain & Ireland, 2010/06/29, Without Invitation, St Andrews (Scotland), UK
  83. Molecular basis of intestinal and gastric phenotypes of gastric cancer, Wataru Yasui, The 17th Seoul International Cancer Symposium, 2010/06, With Invitation, Seoul (Korea)
  84. Analyses of novel genes necoding secreted and transmembrane proteins identified by CAST method: Cdon is highly expressed in prostate cancer, Hayashi T, Oue N, Anami K, Sakamoto N, Sentani K, Ohara S, Teishima J, Matsubara A and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  85. Desmocollin 2 (DSC2), identified by CAST method, is associated with intestinal phenotype of gastric cancer, Anami K, Oue N, Sakamoto N, Hayashi T, Ohara S, Sentani K, Noguchi T and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  86. Serial Analysis of gene expression (SAGE) of esophageal squamous cell carcinoma: ADAMTS-16 is up-regulated in esophageal squamous cell carcinoma, Sakamoto N, Oue N, Noguchi T, Sentani K, Anami K, Sanada Y, Yoshida K and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  87. Inhibition of platelet derived growth factor receptor tyrosine kinase reduces lymphangiogenesis of human gastrointestinal cancer., Kodama M, Kitadai Y, Sumida T, Ohnishi M, Ohara E, Shinagawa K, Tanaka M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  88. Inhibition of platelet-derived growth factor receptor tyrosine kinase reduces tumor growth and metastasis in an orthotopic nude mice model of human gastric cancer, Sumida T, Kitadai Y, Ohnishi M, Ohara E, Shinagawa K, Tanaka M, Kodama M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  89. CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium, Takakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, Okajima M, Yasui W and Ohdan H, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  90. Significance of mesenchymal stem cells in growth and metastasis of colon cancer, Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  91. Usefulness of Reg IV and claudin-18 immunostaining in the diagnosis of gastrointestinal signet ring cell carcinoma, Sentani K, Oue N, Anami K and Yasui W, 8th International Gastric Cancer Congress, 2009/06/10, Without Invitation, Krakow (Poland)
  92. Identification of novel genes encoding secretory and transmembrane protein in gastric cancer using CAST method, Anami K, Oue N, Sakamoto N, Hayashi T, Ohara S, Motoshita J, Noguchi T and Yasui W, 8th International Gastric Cancer Congress, 2009/06/10, Without Invitation, Krakow (Poland)
  93. Identification of potential therapeutic targets in gastric cancer by basic and translational research-state of art lecture-, Wataru Yasui, 8th International Gastric Cancer Congress, 2009/06, With Invitation, Krakow (Poland)
  94. Olfactomedin 4 in combination with Reg IV have utility in the early detection of gastric cancer, Oue N, Sentani K, Sakamoto N, Noguchi T, Ito R and Yasui W, The 100th Annual Meeting of the American Association for Cancer Research, 2009/04/18, Without Invitation, Denver, Colorado (USA)
  95. Reg IV expression in cancer of the prostate, kidney, and urinary tract: frequent expression of Reg IV in prostate cancer, Ohara S, Ito R, Oue N, Hayashi T, Matsubara A and Yasui W, The 100th Annual Meeting of the American Association for Cancer Research, 2009/04/18, Without Invitation, Denver, Colorado (USA)
  96. Reg IV and claudin-18 are novel markers in the diagnosis of gastrointestinal signet ring cell carcinoma, Sentani K, Oue N, Sakamoto N, Taniyama K and Yasui W, The 18th International Symposium of the Hiroshima Cancer Seminar, 2008/11/09, Without Invitation, Hiroshima (Japan)
  97. Novel biomarkers identified through SAGE data analysis in colorectal cancer, Wataru Yasui, The 18th International Symposium of the Hiroshima Cancer Seminar, 2008/11, With Invitation, Hiroshima (Japan)
  98. Olfactomedin 4 and Reg IV: Novel serum biomarkers for gastric cancer patients, Oue N, Sentani K, Sakamoto N, Noguchi T and Yasui W, 36th Congress of the International Society of Oncology and Biomarkers, 2008/10/05, Without Invitation, Tokyo (Japan)
  99. Immunohistochemical analysis and serum concentration of Reg IV in patients with esophageal cancer, Anami K, Oue N, Sentani K, Sakamoto N, Noguchi T and Yasui W, 36th Congress of the International Society of Oncology and Biomarkers, 2008/10/05, Without Invitation, Tokyo (Japan)
  100. Novel biomarker of gastrointestinal cancers identified by Transcriptome Dissection, Yasui W, Oue N, Sentani K, and Sakamoto N, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/09, With Invitation, Oxford (UK)
  101. The correlation between LI-cadherin and EGFR in gastric cancer, Sakamoto N, Oue N, Sentani K and Yasui W, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/08/31, Without Invitation, Oxford (UK)
  102. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for gastric hepatoid carcinoma, Sentani K, Oue N, Sakamoto N and Yasui W, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/08/31, Without Invitation, Oxford (UK)
  103. Recent Topics: Molecular Pathobiology of gastric cancer, Wataru Yasui, The 8th Korea-Japan Gastrointestinal Pathology Seminar, 2008/02, With Invitation, Yokohama (Japan)
  104. Serum Concentration of Reg IV in patients with colorectal cancers, Oue N, Sentani K, Sakamoto N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  105. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach, Sentani K, Oue N, Sakamoto N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  106. Reg IV is an independent prognostic indicator of relapse of prostate cancer, Ohara S, Hayashi T, Matsubara A, Usui T, Oue N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  107. The effect of activity outside the field of view in estimation of human neuroreceptor binding with PET, Shiraishi T, Shidahara M, Tanimoto K, Ando A, Miyamoto T, Koganezawa R, Fukuda H, Yasui W, Ito K and Watanabe K, 2007 Annual Congress of the European Association of Nuclear Medicine, 2007/11/10, Without Invitation, Copenhagen (Denmark)
  108. Transcriptome dissection of gastric cancer through serial analysis of gene expression to identify novel diagnostic and therapeutic targets, Wataru Yasui, The 14th Seoul International Cancer Symposium, 2007/11, With Invitation, Seoul (Korea)
  109. Microsatellite instability in colorectal cancers among atomic-bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Takahashi K, Imai K, Katayama H, Kodama K, Tahara E, Izumi S, Matsumura S, Oue N, Yasui W and Nakachi K, 13th International Congress of Radiation Research, 2007/07/08, Without Invitation, San Francisco, California (USA)
  110. Identification of new serum marker for gastric cancer through SAGE data analysis, Yasui W and Oue N, The 19th Federation of Asia and Oceanian Biochemists and Molecular Biologists (FAOBMB) Conference, 2007/05, With Invitation, Seoul (Korea)
  111. Increased peritoneal metastasis of reg IV-transfected MKN28 gastric carcinoma cells, Kuniyasu H, Kitadai Y, Oue N, Sasahira T, Ohmori H and Yasui W, The 98th Annual Meeting of the American Association for Cancer Research, 2007/04/14, Without Invitation, Los Angeles, California (USA)
  112. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms, Kodama M, Kitadai Y, Tanaka M, Sumida T, Tanaka S, Oue N, Yasui W, Fujii K and Chayama K, The 98th Annual Meeting of the American Association for Cancer Research, 2007/04/14, Without Invitation, Los Angeles, California (USA)
  113. RegIV overexpression inhibits apoptosis, Oue N, Mitani Y, Kamata N and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  114. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer, Hasegawa Y, Matsubara A, Teishima J, Seki M, Mita K, Usui T, Oue N and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  115. Mutations of TP53, KRAS, and EGFR genes in lung cancer from atomic bomb survivors, Taga M, Eguchi H, Hamatani K, Ito R, Katayama H, Kodama K, Tahara E, Matsumura S, Yasui W and Nakachi K, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  116. Microsatellite instability in colorectal cancers among atomic-bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Katayama H, Kodama K, Tahara E, Matsumura S, Yasui W and Nakachi K, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  117. Increased peritoneal metastasis of RegIV-transfected MKN28 gastric carcinoma cells, Kuniyasu H, Oue N, Sasahira T, Mitani Y, Ohmori H and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan),
  118. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion, Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W and Kikuchi A, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  119. Molecular pathology of gastrointestinal carcinoma: Epigenetic alterations and its diagnostic application, Yasui W, The 5th International Group Training Course of "Histopathological Diagnosis of Early Esophagogastric and Colorectal Carcinomas" (Japan International Cooperation Agency; JICA), 2006/09/07, With Invitation, Japan International Cooperation Agency, Hiroshima (Japan)
  120. High expression of h-Prune in gastric cancer with gastric phenbotype: expression of h-prune is associated with poor survival in gastric cance, Oue N, Kikuchi A and Yasui W, The 11th International Congress of Metastasis Research Society jointed with the 15th Annual Meeting of Japanese Association for Metastasis Research, 2006/09/03, Without Invitation, Tokushima (Japan)
  121. Molecular pathogenesis of gastrointestinal neoplasia: Stomach, Yasui W, Aung PP, Nakayama H and Oue N, The XXVI International Congress of the International Academy of Pathology, 2006/09, With Invitation, Montréal (Canada)
  122. Systematic search for novel biomarker of gastric cancer through SAGE data analysis, Wataru Yasui, The 4th International Conference on Gastroenterological Carcinogenesis, 2006/08, With Invitation, Honolulu, Hawaii (USA)
  123. Systematic collection of tissue specimens and molecular pathological analysis of newly diagnosed solid cancers among Atomic-bomb survivors, Wataru Yasui, The Second Nagasaki Symposium of International Consortium for Medical Care of Hibakusha and Radiation Life Science, 2006/07, With Invitation, Nagasaki (Japan)
  124. p53, EGFR and K-ras mutations in lung cancer among atomic bomb survivors, Taga M, Hagiwara N, Mechanic L, Hussain P, Harris CC, Eguchi H, Ito R, Hamatani K, Imai K, Kodama K, Katayama K, Cologne JB, Tahara E, Nakachi K and Yasui W, The workshop on US-Japan cooperative cancer research program, 2006/02, Without Invitation, Washington (USA)
  125. Molecular analysis on colorectal cancer in atomic bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Kodama K, Katayama H, Tahara E, Nakachi K, Matsumura S and Yasui W, The workshop on US-Japan cooperative cancer research program, 2006/02, Without Invitation, Washington (USA)
  126. Down-regulation of claudin-18 and its prognostic impact in gastric cancer, Sanada Y, Oue N, Mitani Y, Aung PP, Yoshida K and Yasui W, The 15th International Symposium of The Hiroshima Cancer Seminar, 2005/10/30, Without Invitation, Hiroshima (Japan)
  127. MAGE gene expression is correlated with resistance to taxan in gastric cancer, Oue N, Suzuki T, Yoshida K and Yasui W, The 15th International Symposium of the Hiroshima cancer Seminar, 2005/10/30, Without Invitation, Hiroshima (Japan)
  128. Identification of MIA as a cancer specific gene and prognostic indicator in gastric cancer, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 6th International Gastric Cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  129. Aberrant methylation of three genes associated with retinoid signaling pathway in human gastric cancer, Shutoh M, Oue N, Aung PP, Noguchi T, Nakayama H, Kawahara K and Yasui W, The 6th International Gastric Cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  130. Expression and effect of cadherin 17 on human gastric carcinomas, Ito R, Oue N, Yoshida Y, Nakayama H, Nakachi K and Yasui W, The 6th International Gastric cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  131. Screening of cancer specific gene and identification of MIA as a cancer specific gene and prognostic indicator in gastric cancer, Aung PP, Oue N, and Yasui W, The 96th Annual Meeting of the American Association for Cancer Research, 2005/04/16, Without Invitation, Anaheim, California (USA)
  132. Identification of novel genes of gastric cancer through serial analysis of gene expression, Wataru Yasui, The 10th US Japan Clinical Trial Summit Meeting: NEW Era of Gastric and Colorectal Cancer Treatment, 2005/02, With Invitation, Maui, Hawaii (USA)
  133. Identification of genes potentially involved in gastric carcinogenesis through serial analysis of gene expression, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 25th International Congress of the International Academy of Pathology, 2004/10/10, Without Invitation, Brisbane (Australia),
  134. Caveolin-1 is specifically expressed in human gastric cancer, Ito R, Oue N, Yoshida K, Nakachi K and Yasui W, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08/19, Without Invitation, Sapporo (Japan)
  135. Search for novel genes of gastric cancer through serial analysis of gene expression, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08/19, Without Invitation, Sapporo (Japan)
  136. Identification of genes involved in invasion and metastasis of gastric cancer by serial analysis of gene expression, Yasui W, Oue N, Mitani Y, Hamai Y, Ito R and Nakayama H, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08, With Invitation, Sapporo (Japan)
  137. Expression of cadherin-17 is associated with advanced stage of gastric carcinoma, Ito R, Oue N, Motoshita J, Nakayama H, Kuraoka K, Yoshida K and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  138. A single nucleotide polymorphism in the MMP-9 promoter is correlated with tumor progression and malignant phenotype of gastric cancer, Matsumura S, Oue N, Hamai Y, Kitadai Y, Chayama K, Yoshida K, Imai K, Nakachi K and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  139. DNA hyper methylation and histone hypoacetylation of the HLTF gene is associated with reduced expression in gastric carcinoma, Hamai Y, Oue N, Mitani Y, Ito R, Matsusaki K, Yoshida K, Toge T and Yasui W, The 95th Annual Meeting of the American Association for cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  140. Histone hypoacetylation and reduced expression of p21waf1 in gastric carcinoma, Mitani Y, Oue N, Nakayama H, Sugiyama M, Ishikawa T and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  141. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis using serial analysis of gene expression, Oue N, Hamai Y, Mitani Y, Matsumura S, Aung PP, Kuraoka K, Yoshida K, Nakayama H and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  142. Molecular pathology of gastric cancer and its diagnostic application, Wataru Yasui, Fifth People Hospital affiliated to Fudan University, 2003/11, With Invitation, Shanghai (China)
  143. Search for novel markers of gastric cancer through global analysis of gene expression profiles and its clinical implication, Wataru Yasui, "Research Institute of Surgery, Third Military Medical University", 2003/11, With Invitation, Chongqing (China)
  144. Search for new biomarkers of gastric cancer through serial analysis of gene expression, Wataru Yasui, The 13th International Symposium of the Hiroshima Cancer Seminar, 2003/10, With Invitation, Hiroshima (Japan)
  145. Expression of Cbl and its correlation with EGFR expression in gastric carcinomas, Ito R, Oue N, Kuraoka K, Yoshida K, Nakayama H and Yasui W, The 94th Annual Meeting of the American Association for Cancer Research, 2003/07/11, Without Invitation, Washington, D.C. (USA)
  146. Helicobacter pylori infection enhances gene expression related to angiogenesis and invasion by human gastric carcinoma cells, Kitadai Y, Sasaki a, Tanaka S, Oue N, Yasui W and Chayama K, The 94th Annual Meeting of the American Association for cancer Research, 2003/07/11, Without Invitation, Washington, D.C. (USA)
  147. Expression of RhoC is associated with metastasis of gastric carcinomas, Kondo T, Sentani K, Oue N, Matsumura S, Ito R, Nakayama H and Yasui W, The 12th International Symposium of the Hiroshima Cancer Seminar, 2002/11/10, Without Invitation, Hiroshima (Japan)
  148. Expression of PRL-3, a metastasis related phosphatase gene, in human gastric carcinomas, Yokozaki H, Oue N, Maskad UA, Kato H Matsumoto N, Semba S and Yasui W, The 12th international Symposium of the Hiroshima Cancer Seminar, 2002/11/10, Without Invitation, Hiroshima (Japan)
  149. Altered histone acetylation and gene expression in gastrointestinal cancer, Wataru Yasui, "RERF (Radiation Effects Research Foundation) Lecture, Special lecture", 2002/09, With Invitation, Hiroshima (Japan)
  150. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa, Kitadai Y, Amioka T, Tanaka S, Akagi M, Yasui W and Chayama K, The 93rd Annual Meeting of the American Association for Cancer Research, 2002/04/06, Without Invitation, San Francisco, California (USA)
  151. Altered histone acetylation and gene expression in human cancers, Wataru Yasui, "NCI Special Meeting ""Epigenetic Mechanisms in Human Disease""", 2002/03, With Invitation, Bethesda, Maryland (USA)
  152. Molecular mechanism of gastrointestinal carcinogenesis and its application to Molecular diagnosis, Wataru Yasui, The 5th International Conference of the Asian Clinical Oncology Society, 2001/04, With Invitation, Taipei (Chinese Taipei)
  153. Interleukin-15 expression is associated with malignant potential in colon cancer cells, Kuniyasu H, Oue N, Fujimoto J, Yokozaki H and Yasui W, The 92nd Annual Meeting of The American Association for Cancer Research, 2001/03/24, Without Invitation, New Orleans, Louisiana (USA)
  154. CpG island methylation of hMLH1, p16, E-cadherin and MGMT and the expression of DNA methyltransferase and demethylase in gastric carcinomas, Oue N, Kuniyasu H, Yokozaki H, Fujimoto J, Kuraoka K and Yasui W, The Fifth Joint Conference of the American association for Cancer Research and the Japanese Cancer Association, 2001/02/12, Without Invitation, Maui, Hawaii (USA)
  155. Practical molecular-pathological diagnosis of gastrointestinal tumors, Wataru Yasui, The 7th International Symposium of the Aichi Cancer Center, 2001/01, With Invitation, Nagoya (Japan)
  156. Molecular-pathological diagnosis system using routine histopathology specimens, Wataru Yasui, The 10th International Symposium of the Hiroshima Cancer Seminar, 2000/10, With Invitation, Hiroshima (Japan)
  157. Molecular diagnosis of gastrointestinal tumors, Yokozaki H and Yasui W, The 22nd International Congress of the International Academy of Pathology, 2000/10, With Invitation, Nagoya (Japan)
  158. Molecular-pathological apects of stomach carcinogenesis and its application to molecular diagnosis, Wataru Yasui, The 22nd International Congress of the International Academy of Pathology, 2000/10, With Invitation, Nagoya (Japan)
  159. Growth inhibition by retinoic acid and its molecular mechanism in oral carcinoma cells, Wataru Yasui, The 4th International Conference of the Asian Clinical Oncology Society, 1999/08, With Invitation
  160. Molecular mechanism of gastric carcinogenesis and molecular diagnosis, The 3rd International Gastric Cancer Congress, 1999/04, With Invitation
  161. Recent advances in molecular mechanisms of human stomach carcinogenesis, Wataru Yasui, The Second International Conference on Gastroenterological Carcinogenesis, 1999/03, With Invitation
  162. Gastric Carcinoma - State of the Art -: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach, Wataru Yasui, The Centennial Anniversary Meeting of the Japanese Society of Gastroenterology", 1998/10, With Invitation
  163. Genetic and epigenetic alterations in gastric cancer. Application to molecular diagnosis, Wataru Yasui, The 17th International Cancer Congress, 1998/08, With Invitation
  164. Future directions: Molecular diagnosis of gastric cancer - Malignant potential -, Wataru Yasui, The 11th International Symposium of the Foundation for Promotion of Cancer Research ''Basic and Clinical Research in Gastric Cancer', 1998/04, With Invitation
  165. Can we regard intestinal metaplasia as a premalignant condition?: From genetic basis, Wataru Yasui, The 11th International Symposium of the Foundation for Promotion of Cancer Research ''Basic and Clinical Research in Gastric Cancer', 1998/04, With Invitation
  166. Molecular diagnosis of early gastric cancer, Wataru Yasui, The 8th Annual Meeting of the Korea University Cancer Research Instititue, 1997/11, With Invitation
  167. Practical molecular diagnosis on gastrointestinal biopsies, Wataru Yasui, The First International Conference on Gastroenterological Carcinogenesis, 1996/10, With Invitation
  168. Molecular biology of stomach cancer and its application to molecular diagnosis, Wataru Yasui, "Special lecture at the Institute of Pathology, University of Erlangen-Nurnberg", 1995/03, With Invitation
  169. Molecular basis of stomach carcinogenesis, Wataru Yasui, WHO-CC 10th International Seminar and Workshop and 5th General Meeting, 1993/09, With Invitation
  170. Gene alterations in intestinal metaplasia and gastric cancer, Wataru Yasui, International Symposium on Helicobacter pylori and its disease, 1993/09, With Invitation
  171. p53 gene abnormalities in human gastric carcinoma, Wataru Yasui, The Second Joint Meeting of American association for Cancer Research and Japanese Cancer Association, 1992/02, With Invitation

Awards

  1. 2013年, Distinguished Professor, Hiroshima University
  2. 2009年11月25日, Hiroshima University President Award, Hiroshima University, Identification of new diagnostic and therapeutic targets of gastric cancer through SAGE data analysis
  3. 2008年05月, Japan Pathology Award, Japanese Society of Pathology, Transcriptome dissection of gastric cancer - Discovery of seeds from tissue sample and its application to diagnosis and treatment -
  4. 2008年02月, Research Grant Award of Prince Takamatsu Cancer Research Fund, Prince Takamatsu Cancer Research Fund, Search for novel diagnostic and therapeutic targets of GI cancer by SAGE and CAST methods
  5. 1997年11月, Japan Pathology Research Award, Japanese Society of Pathology, Molecular pathological diagnosis on biopsy and surgical specimens of gastrointestinal tract

Patented

  1. Patent, JP5055543, 2012/08/10
  2. Patent, JP5467256, 2014/02/07

Social Activities

History as Committee Members

  1. Associate Member, 2017/10/02, 2023/09/30, Science Council of Japan
  2. Associate member, 2006/08/20, 2008/09/30, Science Council of Japan
  3. Vice-chairman, 2016/05, 2018/05, Japanese Society of Pathology
  4. Director, 2014/01, 2019/12, Japanese Cancer Association
  5. Director, 2012/03, 2019/03, Japanese Gastric Cancer Association
  6. Director, 2004, International Society of Gastroenterological Carcinogenesis
  7. Council member, 2016, International Gastric Cancer Association
  8. Councilor, 1998, Japanese Society for Metastasis Research
  9. Executive Director, 2000/06, Hiroshima Cancer Seminar Foundation
  10. Hiroshima Prefecture Medical Council committee member, 2014/08, Hiroshima Prefecture
  11. Hiroshima Prefecture Cancer Control Committee member, 2015/11, Hiroshima Prefecture
  12. Director, 2014/04/01, NPO Promotion of Pathology for Cancer Patient Care
  13. Director, 2012/04/02, NPO Integrated Telemedicine Support Organization
  14. NHK Chugoku Broadcast Program Council Committee member, 2015/05, 2017/04, NKH Hiroshima Broadcasting Station
  15. President, The 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, 2017/03, Japanese Gastric Cancer Association
  16. President, The 103rd Annual Meeting of the Japanese Society of Pathology, 2014/04/26, 2014/04/28, Japanese Society of Pathology
  17. President, The 26th Annual Meeting of the Japanese Association for Metastasis Research, 2011/07, 2012/07, Japanese Association for Metastasis Research
  18. President, The 30th Annual Meeting of the Japan Society for Molecular Tumor Marker Research, 2010/09, 2010/09, Japan Society for Molecular Tumor Marker Research
  19. President, The 20th Annual Meeting of the Japanese Society of Gastroenterological Carcinogenesis, 2009/11/26, 2009/11/27, Japanese Society of Gastroenterological Carcinogenesis
  20. President, The First Conference of the Japanese Society of Pathology, 2004/07, 2004/07, Japanese Society of Pathology
  21. President, The 23rd Annual Meeting of the Japanese Research Society of Molecular Pathology, 2004/07, 2004/08, Japanese Research Society of Molecular Pathology

History as Peer Reviews of Academic Papers

  1. 2017, Pathobiology, Editor Far East
  2. 2017, Cancer Science, Associate Editor
  3. 2017, Pathology International, Editorial Board
  4. 2017, Oncology, Editorial Board
  5. 2017, Japanese Journal of Clinical Oncology, Associate Editor
  6. 2017, Gastric Cancer, Editor
  7. 2017, Gastric Cancer Perspective, Editor
  8. 2017, International Journal of Clinical Oncology, Editorial Board
  9. 2016, Pathobiology, Editor-Far East
  10. 2016, Gastric Cancer, Editor
  11. 2016, Cancer Science, Associate Editor
  12. 2016, Pathology International, Editorial Board
  13. 2016, Oncology, Editorial Board
  14. 2016, Japanese Journal of Clinical Oncology, Associate Editor
  15. 2016, Gastric Cancer Perspective, Editor
  16. 2016, International Journal of Clinical Oncology, Editorial Board
  17. 2015, Pathobiology, Editor-Far East
  18. 2015, Cancer Science, Associate Editor
  19. 2015, Gastric Cancer, Editor
  20. 2015, Japanese Journal of Clinical Oncology, Associate Editor
  21. 2015, Oncology, Editorial Board
  22. 2015, Pathology International, Editorial Board
  23. 2015, Gastric Cancer Perspective, Editor
  24. 2014, Pathology and Clinical Medicine, Editor
  25. 2014, Gastric Cancer Perspective, Editor